|
North Carolina
|
| |
6531
|
| |
82-1518164
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification Number) |
|
|
Please send copies of all communications to:
|
| |||
|
Donald R. Reynolds
Andrew J. Gibbons Lorna A. Knick Wyrick Robbins Yates & Ponton LLP 4101 Lake Boone Trail, Suite 300 Raleigh, North Carolina 27607 (919) 781-4000 |
| |
M. Ali Panjwani, Esq.
Pryor Cashman LLP 7 Times Square New York, New York 10036 (212) 421-4100 |
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
| | | |
Emerging growth company
☒
|
|
| | ||||||||||||||
Title of Each Class of Securities to be Registered
|
| | |
Proposed Maximum
Aggregate Offering Price(1) |
| | |
Amount of
Registration Fee |
| ||||||
Common Stock, no par value per share(2)
|
| | | | $ | 21,500,000 | | | | | | $ | 2,790.70 | | |
Underwriter Warrants(3)
|
| | | | $ | — | | | | | | | | | |
Common Stock underlying Underwriter Warrants(4)
|
| | | | $ | 1,540,000 | | | | | | $ | 199.89 | | |
Selling Shareholder(5)
|
| | | | $ | 1,500,000 | | | | | | $ | 194.70 | | |
Total
|
| | | | $ | 24,540,000 | | | | | | $ | 3,185.29(6)(7) | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 8 | | | |
| | | | 10 | | | |
| | | | 12 | | | |
| | | | 29 | | | |
| | | | 30 | | | |
| | | | 31 | | | |
| | | | 32 | | | |
| | | | 33 | | | |
| | | | 44 | | | |
| | | | 46 | | | |
| | | | 56 | | | |
| | | | 61 | | | |
| | | | 70 | | | |
| | | | 71 | | | |
| | | | 73 | | | |
| | | | 75 | | | |
| | | | 77 | | | |
| | | | 80 | | | |
| | | | 88 | | | |
| | | | 88 | | | |
| | | | 88 | | | |
| | | | F-1 | | |
| Arizona | | | Indiana | | | Ohio | |
| Arkansas | | | Kentucky | | | Oklahoma | |
| California | | | Louisiana | | | Oregon | |
| Colorado | | | Maryland | | | South Carolina | |
| District of Columbia | | | Missouri | | | Tennessee | |
| Florida | | | Nevada | | | Texas | |
| Georgia | | | New Jersey | | | Virginia | |
| Illinois | | | North Carolina | | | Washington | |
| | |
Years ended December 31,
|
| |
Three months ended March 31,
|
| ||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
Statement of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
|
| | | $ | 77,305,562 | | | | | $ | 109,621,943 | | | | | $ | 18,134,726 | | | | | $ | 28,838,831 | | |
Cost of revenue
|
| | | | 73,436,660 | | | | | | 103,672,899 | | | | | | 16,852,772 | | | | | | 26,687,256 | | |
Gross profit
|
| | | | 3,868,902 | | | | | | 5,949,044 | | | | | | 1,281,954 | | | | | | 2,151,575 | | |
General and administrative
|
| | | | 5,130,920 | | | | | | 9,599,050 | | | | | | 2,662,045 | | | | | | 1,930,076 | | |
Marketing
|
| | | | 255,090 | | | | | | 340,582 | | | | | | 57,762 | | | | | | 230,433 | | |
Total operating expenses
|
| | | | 5,386,010 | | | | | | 9,939,632 | | | | | | 2,719,807 | | | | | | 2,160,509 | | |
Loss from operations
|
| | | | (1,517,108) | | | | | | (3,990,588) | | | | | | (1,437,853) | | | | | | (8,934) | | |
Other expense, net | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense, net
|
| | | | 102,123 | | | | | | 109,709 | | | | | | 27,370 | | | | | | 32,837 | | |
Other expense
|
| | | | 16,819 | | | | | | — | | | | | | — | | | | | | — | | |
Other expense, net
|
| | | | 118,942 | | | | | | 109,709 | | | | | | 27,370 | | | | | | 32,837 | | |
Loss from operations before income taxes
|
| | | | (1,636,050) | | | | | | (4,100,297) | | | | | | (1,465,223) | | | | | | (41,771) | | |
Income tax (expense) benefit
|
| | | | (27,155) | | | | | | 8,000 | | | | | | (4,020) | | | | | | (1,000) | | |
Net loss
|
| | | $ | (1,663,205) | | | | | $ | (4,092,297) | | | | | $ | (1,469,243) | | | | | $ | (42,771) | | |
Net loss per share | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and Diluted
|
| | | $ | (0.20) | | | | | $ | (0.42) | | | | | $ | (0.15) | | | | | $ | (0.00) | | |
Weighted average common shares outstanding
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Basic and Diluted
|
| | | | 8,264,547 | | | | | | 9,804,988 | | | | | | 9,655,644 | | | | | | 9,993,866 | | |
| | |
As of December 31,
|
| | ||||||||||||||
| | |
2018
|
| |
2019
|
| |
As of March 31, 2020
|
| |||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||
Balance Sheet Data: | | | | | |||||||||||||||
Cash and cash equivalents
|
| | | $ | 1,008,538 | | | | | $ | 579,416 | | | | | $ | 844,449 | | |
Working capital
|
| | | | 525,791 | | | | | | (1,282,468) | | | | | | (1,229,223) | | |
Total assets
|
| | | | 3,834,139 | | | | | | 2,490,033 | | | | | | 3,901,027 | | |
Loan payable, net of current portion
|
| | | | 52,188 | | | | | | 35,093 | | | | | | 30,773 | | |
Note payable
|
| | | | 500,000 | | | | | | 500,000 | | | | | | 500,000 | | |
Lease liability, net of current portion
|
| | | | — | | | | | | 177,578 | | | | | | 167,261 | | |
Total stockholders’ equity (deficit)
|
| | | | 232,042 | | | | | | (1,159,185) | | | | | | (994,221) | | |
| | |
As of March 31, 2020
(Unaudited) |
| |||||||||||||||
| | |
Actual
|
| |
Pro Forma
|
| |
Pro Forma
As Adjusted |
| |||||||||
Cash and cash equivalents
|
| | | $ | 844,449 | | | | | $ | 844,449 | | | | | $ | 18,844,449 | | |
Notes Payable
|
| | | | 500,000 | | | | | | 500,000 | | | | | | 500,000 | | |
Loan Payable (including short-term maturities of $17,169)
|
| | | | 47,942 | | | | | | 47,942 | | | | | | 47,942 | | |
Total Debt
|
| | | | 547,942 | | | | | | 547,942 | | | | | | 547,942 | | |
Stockholders’ deficit: | | | | | | | | | | | | | | | | | | | |
Common stock, $0.00 par value, 100,000,000 authorized and
10,223,168 shares issued and outstanding, actual; 100,000,000 shares authorized, 12,723,168 shares issued and outstanding, as adjusted |
| | | | — | | | | | | — | | | | | | — | | |
Additional paid-in-capital
|
| | | | 5,196,117 | | | | | | 5,196,117 | | | | | | 23,196,117 | | |
Accumulated deficit
|
| | | | (6,190,338) | | | | | | (6,190,338) | | | | | | (6,190,338) | | |
Total stockholders’ deficit
|
| | | | (994,221) | | | | | | (994,421) | | | | | | 17,005,779 | | |
Total Capitalization
|
| | | $ | (446,279) | | | | | $ | (446,279) | | | | | $ | 17,553,721 | | |
|
Assumed initial public offering price
|
| | | $ | 8.00 | | |
|
Pro forma net tangible book value per share as of March 31, 2020
|
| | | $ | (0.10) | | |
|
Increase per share attributable to this offering
|
| | | $ | 1.44 | | |
|
Pro forma as adjusted net tangible book value per share after this offering
|
| | | $ | 17,005,779 | | |
|
Net tangible book value dilution per share to investors in this offering
|
| | | $ | 6.66 | | |
| | |
Shares Purchased
|
| |
Total Consideration
|
| |
Average Price
per Share |
| |||||||||||||||||||||
| | |
Number
|
| |
Percentage
|
| |
Amount
|
| |
Percentage
|
| ||||||||||||||||||
Existing Shareholders
|
| | | | 10,223,168 | | | | | | 80% | | | | | $ | 5,196,117 | | | | | | 21% | | | | | $ | 0.51 | | |
New Investors
|
| | | | 2,500,000 | | | | | | 20% | | | | | | 20,000,000 | | | | | | 79% | | | | | | 8.00 | | |
Total
|
| | | | 12,723,168 | | | | | | 100% | | | | | | 25,196,117 | | | | | | 100% | | | | | $ | 1.98 | | |
| | |
December 31,
|
| |
December 31,
|
| | | | | | | |
March 31,
|
| |
March 31,
|
| | | | | | | ||||||||||||
| | |
2018
|
| |
2019
|
| |
Change
|
| |
2018
|
| |
2019
|
| |
Change
|
| ||||||||||||||||||
Agents
|
| | | | 2,724 | | | | | | 4,006 | | | | | | 47% | | | | | | 3,089 | | | | | | 4,258 | | | | | | 38% | | |
| | |
Three months ended March 31,
|
| |
Change
|
| | ||||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
Dollars
|
| |
Percentage
|
| | ||||||||||||||
| | |
(Unaudited)
|
| | | | | | | | | | | | | | | | |||||||||
Revenue
|
| | | $ | 18,134,726 | | | | | $ | 28,838,831 | | | | | $ | 10,704,105 | | | | | | 59% | | | |
| | |
Three months ended March 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
| | |
(Unaudited)
|
| | | |||||||||||||||||||
Cost of revenue
|
| | | $ | 16,852,772 | | | | | $ | 26,687,256 | | | | | $ | 9,834,484 | | | | | | 58% | | |
| | |
Three months ended March 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
| | |
(Unaudited)
|
| | | | | | | | | | | | | |||||||||
General and administrative
|
| | | $ | 2,662,045 | | | | | $ | 1,930,076 | | | | | $ | (731,969) | | | | | | (27)% | | |
Marketing
|
| | | | 57,762 | | | | | | 230,433 | | | | | | 172,671 | | | | | | 299% | | |
Total operating expenses
|
| | | $ | 2,719,807 | | | | | $ | 2,160,509 | | | | | $ | (559,298) | | | | | | (21)% | | |
| | |
Years ended December 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
Revenue
|
| | | $ | 77,305,562 | | | | | $ | 109,621,943 | | | | | $ | 32,316,381 | | | | | | 42% | | |
| | |
Years ended December 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
Cost of revenue
|
| | | $ | 73,436,660 | | | | | $ | 103,672,899 | | | | | $ | 30,236,239 | | | | | | 41% | | |
| | |
Years ended December 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
General and administrative
|
| | | $ | 5,130,920 | | | | | $ | 9,599,050 | | | | | $ | 4,468,130 | | | | | | 87% | | |
Marketing
|
| | | | 255,090 | | | | | | 340,582 | | | | | | 85,492 | | | | | | 34% | | |
Total operating expenses
|
| | | $ | 5,386,010 | | | | | $ | 9,939,632 | | | | | $ | 4,553,622 | | | | | | 85% | | |
| | | | | | | | | | | | | | |
Change
|
| |||||||||
| | |
December 31, 2019
|
| |
March 31, 2020
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
| | | | | | | | |
(Unaudited)
|
| | | |||||||||||||
Current assets
|
| | | $ | 1,654,079 | | | | | $ | 2,967,991 | | | | | $ | 1,313,912 | | | | | | 79% | | |
Current liabilities
|
| | | | 2,936,547 | | | | | | 4,197,214 | | | | | | 1,260,667 | | | | | | 43% | | |
Net working capital
|
| | | $ | (1,282,468) | | | | | $ | (1,229,223) | | | | | $ | 53,245 | | | | | | 4% | | |
| | | | | |
Three months ended March 31,
|
| |
Change
|
| ||||||||||||||||||
| | | | | |
2019
|
| |
2020
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
| | | | | |
(Unaudited)
|
| | | | | | | | | | | | | |||||||||
Net cash (used in) provided by operating activities
|
| | | | | | $ | (411,944) | | | | | $ | 303,083 | | | | | $ | 715,027 | | | | | | 174% | | |
Net cash used in investing activities
|
| | | | | | $ | (61,900) | | | | | $ | (116,818) | | | | | $ | (54,918) | | | | | | (89)% | | |
Net cash provided by financing activities
|
| | | | | | $ | 571,827 | | | | | $ | 78,768 | | | | | $ | (493,059) | | | | | | (86)% | | |
| | |
Years ended December 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
Dollars
|
| |
Percentage
|
| ||||||||||||
Net cash used in operating activities
|
| | | $ | (689,173) | | | | | $ | (1,110,972) | | | | | $ | (421,799) | | | | | | (61)% | | |
Net cash used in investing activities
|
| | | $ | (180,217) | | | | | $ | (372,816) | | | | | $ | (192,599) | | | | | | (107)% | | |
Net cash provided by financing activities
|
| | | $ | 1,723,490 | | | | | $ | 1,054,666 | | | | | $ | (668,824) | | | | | | (39)% | | |
| | |
For the Year Ended
|
| |
For the Three Months Ended
|
| ||||||||||||||||||
| | |
December 31, 2018
|
| |
December 31, 2019
|
| |
March 31, 2019
|
| |
March 31, 2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
Net loss
|
| | | $ | (1,663,205) | | | | | $ | (4,092,297) | | | | | $ | (1,469,243) | | | | | $ | (42,771) | | |
Other expense, net
|
| | | | 118,942 | | | | | | 109,709 | | | | | | 27,370 | | | | | | 32,837 | | |
Income tax expense (benefit)
|
| | | | 27,155 | | | | | | (8,000) | | | | | | 4,020 | | | | | | 1,000 | | |
Depreciation & amortization
|
| | | | 23,400 | | | | | | 60,441 | | | | | | 6,022 | | | | | | 19,275 | | |
Restricted stock award compensation expense
|
| | | | 253,353 | | | | | | 1,570,151 | | | | | | 910,092 | | | | | | 103,158 | | |
Stock option compensation expense
|
| | | | — | | | | | | 59,453 | | | | | | — | | | | | | 21,563 | | |
Adjusted EBITDA
|
| | | $ | (1,240,355) | | | | | $ | (2,300,543) | | | | | $ | (521,739) | | | | | $ | 135,062 | | |
|
Arizona
|
| | Indiana | | | Ohio | |
|
Arkansas
|
| | Kentucky | | | Oklahoma | |
|
California
|
| | Louisiana | | | Oregon | |
|
Colorado
|
| | Maryland | | | South Carolina | |
|
District of Columbia
|
| | Missouri | | | Tennessee | |
|
Florida
|
| | Nevada | | | Texas | |
|
Georgia
|
| | New Jersey | | | Virginia | |
|
Illinois
|
| | North Carolina | | | Washington | |
Name
|
| |
Age
|
| |
Position
|
|
Joshua Harley | | |
43
|
| | Chairman, Chief Executive Officer, Director | |
Marco Fregenal | | |
56
|
| | President and Chief Financial Officer, and Director | |
Samantha Giuggio | | |
50
|
| | Chief Broker Operations Officer | |
Chris Bennett | | |
39
|
| | Director | |
Jeffrey Coats | | |
62
|
| | Director | |
David C. Hood | | |
58
|
| | Director | |
Glenn Sampson | | |
79
|
| | Director | |
Jennifer Venable | | |
49
|
| | Director | |
Name and principal position
|
| |
Fiscal
Year |
| |
Salary
($)(1) |
| |
Bonus
($) |
| |
Stock
awards ($) |
| |
Option
awards ($) |
| |
All other
compensation ($) |
| |
Total
($) |
| |||||||||||||||||||||
Joshua Harley,
Chief Executive Officer |
| | | | 2019 | | | | | $ | 379,167 | | | | | $ | 176,050 | | | | | | — | | | | | | — | | | | | $ | 11,112(2) | | | | | $ | 566,329 | | |
| | | 2018 | | | | | $ | 381,095 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 31,140(3) | | | | | $ | 412,235 | | | ||
| | | 2017 | | | | | $ | 372,500 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 7,802 (4) | | | | | $ | 380,302 | | | ||
Marco Fregenal,
President and Chief Financial Officer |
| | | | 2019 | | | | | $ | 416,846 | | | | | $ | 164,830 | | | | | | — | | | | | | — | | | | | $ | 8,128(5) | | | | | $ | 589,804 | | |
| | | 2018 | | | | | $ | 397,157 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 22,808 (6) | | | | | $ | 419,965 | | | ||
| | | 2017 | | | | | $ | 283,397 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 28,830 (7) | | | | | $ | 312,227 | | | ||
Samantha Giuggio,
Chief Broker Operations Officer |
| | | | 2019 | | | | | $ | 177,000 | | | | | | — | | | | | $ | 75,000 | | | | | | — | | | | | $ | 11,850(8) | | | | | $ | 263,850 | | |
| | | 2018 | | | | | $ | 140,000 | | | | | | — | | | | | $ | 43,000 | | | | | | — | | | | | $ | 22,422 (9) | | | | | $ | 205,422 | | | ||
| | | 2017 | | | | | $ | 120,000 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 1,510 (10) | | | | | $ | 121,510 | | |
Plan
|
| |
Number of
Shares Issued |
| |
Number of
Shares Reserved for Issuance |
| |
Number of
Shares Underlying Outstanding Options or Warrant |
| |
Number of
Shares Remaining Available for Future Issuance |
| ||||||||||||
2017 Stock Plan
|
| | | | 405,562 | | | | | | 3,182,335 | | | | | | 37,130 | | | | | | 2,739,643 | | |
2019 Omnibus Stock Incentive Plan
|
| | | | 333,346 | | | | | | 1,060,778 | | | | | | — | | | | | | 727,433 | | |
Name
|
| |
Fees earned or
paid in cash ($) |
| |
Option
awards ($)(1) |
| |
All other
compensation ($) |
| |
Total
($) |
| ||||||||||||
Chris Bennett
|
| | | $ | 3,750 | | | | | $ | 25,000 | | | | | | — | | | | | $ | 28,750 | | |
Jeffrey H. Coats
|
| | | $ | 18,750 | | | | | $ | 40,000 | | | | | | — | | | | | $ | 58,750 | | |
Hoshi Printer(2)
|
| | | $ | 30,000 | | | | | $ | 40,000 | | | | | | — | | | | | $ | 70,000 | | |
David C. Hood
|
| | | $ | 15,000 | | | | | $ | 40,000 | | | | | | — | | | | | $ | 55,000 | | |
Glenn Sampson
|
| | | $ | 3,750 | | | | | $ | 25,000 | | | | | | — | | | | | $ | 28,750 | | |
Jennifer Venable
|
| | | $ | 3,750 | | | | | $ | 25,000 | | | | | | — | | | | | $ | 28,750 | | |
| | | | | |
No Exercise
of Underwriters’ Option |
| |
Full Exercise
of Underwriters’ Option |
| |||||||||||||||||||||||||||||||||||||||
| | |
Shares Beneficially
Owned before the Offering |
| |
Shares
Offered Hereby |
| |
Shares Beneficially
Owned after the Offering |
| |
Shares
Offered Hereby |
| |
Shares Beneficially
Owned after the Offering |
| |||||||||||||||||||||||||||||||||
Name of Beneficial Owner
|
| |
Number
|
| |
Percent(1)
|
| |
Number
|
| |
Percent(1)
|
| |
Number
|
| |
Percent(1)
|
| ||||||||||||||||||||||||||||||
Directors and Named Executive Officers: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Joshua Harley
|
| | | | 4,995,459(2) | | | | | | 48.9% | | | | | | — | | | | | | 4,995,459(2) | | | | | | 39.3% | | | | | | — | | | | | | 4,995,459(2) | | | | | | 38.7% | | |
Marco Fregenal
|
| | | | 1,488,635 | | | | | | 14.6% | | | | | | — | | | | | | 1,488,635 | | | | | | 11.7% | | | | | | — | | | | | | 1,488,635 | | | | | | 11.5% | | |
Samantha Giuggio
|
| | | | 31,350(3) | | | | | | * | | | | | | — | | | | | | 31,350(3) | | | | | | * | | | | | | — | | | | | | 31,350(3) | | | | | | * | | |
Christopher Bennett
|
| | | | 5,304(4) | | | | | | * | | | | | | — | | | | | | 5,304(4) | | | | | | * | | | | | | — | | | | | | 5,304(4) | | | | | | * | | |
Jeffrey H. Coats
|
| | | | 8,486(4) | | | | | | * | | | | | | — | | | | | | 8,486(4) | | | | | | * | | | | | | — | | | | | | 8,486(4) | | | | | | * | | |
David C. Hood
|
| | | | 8,486(4) | | | | | | * | | | | | | — | | | | | | 8,486(4) | | | | | | * | | | | | | — | | | | | | 8,486(4) | | | | | | * | | |
Glenn Sampson
|
| | | | 2,356,834(5) | | | | | | 23.1% | | | | | | — | | | | | | 2,356,834(5) | | | | | | 18.5% | | | | | | (187,500) | | | | | | 2,169,334(5) | | | | | | 16.8% | | |
Jennifer B. Venable
|
| | | | 5,304(4) | | | | | | * | | | | | | — | | | | | | 5,304(4) | | | | | | * | | | | | | — | | | | | | 5,304(4) | | | | | | * | | |
All directors and executive officers as a group (8 individuals)
|
| | | | 8,899,858 | | | | | | 86.8% | | | | | | — | | | | | | 8,899,858 | | | | | | 69.8% | | | | | | — | | | | | | 8,712,358 | | | | | | 67.4% | | |
Underwriter
|
| |
Number of Shares
|
|
Roth Capital Partners, LLC
|
| | | |
Total
|
| | |
| | |
Total
|
| |||||||||||||||
| | |
Per Share
|
| |
Without Option
|
| |
With Option
|
| |||||||||
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | |||
Underwriting discounts and commissions (7%)
|
| | | $ | | | | | $ | | | | | $ | | | |||
Proceeds, before expenses, to us
|
| | | $ | | | | | $ | | | | | $ | | | |
| | | | | F-2 | | | |
| Consolidated Financial Statements | | | | | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-7 | | | |
| | | | | F-23 | | | |
| | | | | F-24 | | | |
| | | | | F-25 | | | |
| | | | | F-26 | | | |
| | | | | F-27 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
ASSETS
|
| | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 1,008,538 | | | | | $ | 579,416 | | |
Accounts receivable
|
| | | | 1,494,580 | | | | | | 304,769 | | |
Agent annual fee receivable, net of allowance of $138,030 and $349,420
|
| | | | 322,070 | | | | | | 356,131 | | |
Due from affiliates
|
| | | | 668,597 | | | | | | 2,561 | | |
Prepaid and other current assets
|
| | | | 81,915 | | | | | | 411,202 | | |
Total current assets
|
| | | | 3,575,700 | | | | | | 1,654,079 | | |
Property and equipment, net
|
| | | | 90,619 | | | | | | 105,972 | | |
Capitalized software, net
|
| | | | 167,820 | | | | | | 464,842 | | |
Lease right of use assets
|
| | | | — | | | | | | 265,140 | | |
Total assets
|
| | | $ | 3,834,139 | | | | | $ | 2,490,033 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
| | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable and accrued liabilities
|
| | | $ | 3,023,045 | | | | | $ | 2,806,228 | | |
Due to affiliates
|
| | | | 10,064 | | | | | | 23,658 | | |
Loan payable – current portion
|
| | | | 16,800 | | | | | | 17,095 | | |
Lease liability – current portion
|
| | | | — | | | | | | 89,566 | | |
Total current liabilities
|
| | | | 3,049,909 | | | | | | 2,936,547 | | |
Loan payable, net of current portion
|
| | | | 52,188 | | | | | | 35,093 | | |
Note payable
|
| | | | 500,000 | | | | | | 500,000 | | |
Lease liability, net of current portion
|
| | | | — | | | | | | 177,578 | | |
Total liabilities
|
| | | | 3,602,097 | | | | | | 3,649,218 | | |
Commitments and contingencies | | | | | | | | | | | | | |
Stockholders’ Equity (Deficit): | | | | | | | | | | | | | |
Common stock, $0.00 par value, 100,000,000 authorized and 9,440,061 and 10,211,658 issued and outstanding as of December 31, 2018 and December 31, 2019
|
| | | | — | | | | | | — | | |
Additional paid-in capital
|
| | | | 2,287,312 | | | | | | 4,988,382 | | |
Accumulated deficit
|
| | | | (2,055,270) | | | | | | (6,147,567) | | |
Total stockholders’ equity (deficit)
|
| | | | 232,042 | | | | | | (1,159,185) | | |
Total liabilities and stockholders’ equity
|
| | | $ | 3,834,139 | | | | | $ | 2,490,033 | | |
| | |
Years ended December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Revenue
|
| | | $ | 77,305,562 | | | | | $ | 109,621,943 | | |
Cost of revenue
|
| | | | 73,436,660 | | | | | | 103,672,899 | | |
Gross profit
|
| | | | 3,868,902 | | | | | | 5,949,044 | | |
General and administrative
|
| | | | 5,130,920 | | | | | | 9,599,050 | | |
Marketing
|
| | | | 255,090 | | | | | | 340,582 | | |
Total operating expenses
|
| | | | 5,386,010 | | | | | | 9,939,632 | | |
Loss from operations
|
| | | | (1,517,108) | | | | | | (3,990,588) | | |
Other expense, net | | | | | | | | | | | | | |
Interest expense, net
|
| | | | 102,123 | | | | | | 109,709 | | |
Other expense
|
| | | | 16,819 | | | | | | — | | |
Other expense, net
|
| | | | 118,942 | | | | | | 109,709 | | |
Loss from operations before income taxes
|
| | | | (1,636,050) | | | | | | (4,100,297) | | |
Income tax (expense) benefit
|
| | | | (27,155) | | | | | | 8,000 | | |
Net loss
|
| | | $ | (1,663,205) | | | | | $ | (4,092,297) | | |
Net loss per share | | | | | | | | | | | | | |
Basic and Diluted
|
| | | $ | (0.20) | | | | | $ | (0.42) | | |
Weighted average common shares outstanding | | | | | | | | | | | | | |
Basic and Diluted
|
| | | | 8,264,547 | | | | | | 9,804,988 | | |
| | |
Fathom
Realty Holdings, LLC |
| |
Fathom Realty Group, Inc.
|
| | | | | | | ||||||||||||||||||||||||||||||||||||||||||
| | |
Common
Stock and capital in excess of par |
| | | | | | | |
Fathom Holdings Inc.
|
| | |||||||||||||||||||||||||||||||||||||||||
| | |
Members’
equity |
| |
Retained
earnings |
| |
Series A
Shares |
| |
Common
Stock |
| |
Par
Value |
| |
APIC
|
| |
Accumulated
deficit |
| |
Total
|
| ||||||||||||||||||||||||||||||
Balance at December 31, 2017
|
| | | $ | (179,213) | | | | | $ | — | | | | | $ | 256,364 | | | | | | 85,000,000 | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | (75,431) | | | | | $ | 1,720 | | |
Cancellation of Series A
|
| | | | — | | | | | | — | | | | | | — | | | | | | (85,000,000) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Exchange agreement Fathom Realty Group, Inc.
|
| | | | 325,447 | | | | | | — | | | | | | (325,447) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Purchase of membership units Fathom Realty Holdings , LLC
|
| | | | (70,000) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (70,000) | | |
Issuance of common shares for Intelliagent, LLC (related party)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,337,143 | | | | | | — | | | | | | 174 | | | | | | — | | | | | | 174 | | |
Issuance of common shares for Fathom Realty Holdings, LLC
|
| | | | (323,785) | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,679,472 | | | | | | — | | | | | | 323,785 | | | | | | — | | | | | | — | | |
Issuance of common stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 364,399 | | | | | | — | | | | | | 1,710,000 | | | | | | — | | | | | | 1,710,000 | | |
Share based compensation
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 59,047 | | | | | | — | | | | | | 253,353 | | | | | | — | | | | | | 253,353 | | |
Net income (loss)
|
| | | | 247,551 | | | | | | — | | | | | | 69,083 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,979,839) | | | | | | (1,663,205) | | |
Balance at December 31, 2018
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 9,440,061 | | | | | | — | | | | | | 2,287,312 | | | | | | (2,055,270) | | | | | | 232,042 | | |
Issuance of common stock, net
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 216,194 | | | | | | — | | | | | | 1,071,466 | | | | | | — | | | | | | 1,071,466 | | |
Share-based compensation
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 555,403 | | | | | | — | | | | | | 1,629,604 | | | | | | — | | | | | | 1,629,604 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,092,297) | | | | | | (4,092,297) | | |
Balance at December 31, 2019
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | | — | | | | | | 10,211,658 | | | | | $ | — | | | | | $ | 4,988,382 | | | | | $ | (6,147,567) | | | | | $ | (1,159,185) | | |
|
| | |
Years ended December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (1,663,205) | | | | | $ | (4,092,297) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Depreciation and amortization
|
| | | | 23,400 | | | | | | 60,441 | | |
Bad debt expense
|
| | | | 111,467 | | | | | | 211,390 | | |
Share-based compensation
|
| | | | 253,353 | | | | | | 1,629,604 | | |
Change in operating assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | (134,223) | | | | | | 1,189,811 | | |
Agent annual fees receivable
|
| | | | (88,654) | | | | | | (245,451) | | |
Due from affiliates
|
| | | | (72,191) | | | | | | 666,036 | | |
Prepaid and other assets
|
| | | | (4,127) | | | | | | (329,287) | | |
Accounts payable and accrued liabilities
|
| | | | 885,008 | | | | | | (216,817) | | |
Operating lease right of use assets
|
| | | | — | | | | | | (3,326) | | |
Operating lease liabilities
|
| | | | — | | | | | | 5,330 | | |
Due to affiliates
|
| | | | (1) | | | | | | 13,594 | | |
Net cash used in operating activities
|
| | | | (689,173) | | | | | | (1,110,972) | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | | | |
Purchase of property and equipment
|
| | | | (12,397) | | | | | | (41,336) | | |
Purchase of capitalized software
|
| | | | (167,820) | | | | | | (331,480) | | |
Net cash used in investing activities
|
| | | | (180,217) | | | | | | (372,816) | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | | | |
Principal payments on loan payable
|
| | | | (16,510) | | | | | | (16,800) | | |
Proceeds from issuance of common stock
|
| | | | 1,710,000 | | | | | | 1,071,466 | | |
Proceeds from note payable
|
| | | | 500,000 | | | | | | — | | |
Payments on note payable
|
| | | | (400,000) | | | | | | — | | |
Purchase of Fathom Realty Holdings, LLC membership interest
|
| | | | (70,000) | | | | | | — | | |
Net cash provided by financing activities
|
| | | | 1,723,490 | | | | | | 1,054,666 | | |
Net increase (decrease) in cash and cash equivalents
|
| | | | 854,100 | | | | | | (429,122) | | |
Cash and cash equivalents at beginning of period
|
| | | | 154,438 | | | | | | 1,008,538 | | |
Cash and cash equivalents at end of period
|
| | | $ | 1,008,538 | | | | | $ | 579,416 | | |
Supplemental disclosure of cash and non-cash transactions: | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 102,151 | | | | | $ | 109,856 | | |
Income taxes paid
|
| | | $ | 12,505 | | | | | $ | 1,250 | | |
Issuance of non-voting units for Fathom Realty Group Inc.
|
| | | $ | 325,447 | | | | | $ | — | | |
Issuance of common stock for Fathom Realty Holdings LLC
|
| | | $ | 323,785 | | | | | $ | — | | |
Right of use assets obtained in exchange for lease liabilities
|
| | | $ | — | | | | | $ | 261,814 | | |
Asset category
|
| |
Depreciable life
|
|
Vehicles | | |
7 years
|
|
Computers and equipment | | |
5 years
|
|
Furniture and fixtures | | |
7 years
|
|
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Shares issuable upon exercise of stock options
|
| | | | — | | | | | | 37,130 | | |
Non-vested shares under restricted stock grants
|
| | | | — | | | | | | 227,981 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Vehicles
|
| | | $ | 119,324 | | | | | $ | 119,324 | | |
Computers and equipment
|
| | | | 45,545 | | | | | | 73,115 | | |
Furniture and fixtures
|
| | | | 16,292 | | | | | | 30,058 | | |
Total property and equipment
|
| | | | 181,161 | | | | | | 222,497 | | |
Accumulated depreciation
|
| | | | (90,542) | | | | | | (116,525) | | |
Total property and equipment, net
|
| | | $ | 90,619 | | | | | $ | 105,972 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Software Development
|
| | | $ | 167,820 | | | | | $ | 499,300 | | |
Total capitalized software
|
| | | | 167,820 | | | | | | 499,300 | | |
Accumulated amortization
|
| | | | — | | | | | | (34,458) | | |
Total capitalized software, net
|
| | | $ | 167,820 | | | | | $ | 464,842 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Accounts payable
|
| | | $ | 817,814 | | | | | $ | 922,373 | | |
Accrued professional fees
|
| | | | — | | | | | | 601,797 | | |
Deferred annual fee
|
| | | | 299,291 | | | | | | 463,667 | | |
Accrued commissions
|
| | | | 1,489,246 | | | | | | 261,161 | | |
Accrued compensation
|
| | | | 179,322 | | | | | | 196,948 | | |
Insurance premium liabilities
|
| | | | — | | | | | | 139,891 | | |
Other accrued liabilities
|
| | | | 21,715 | | | | | | 72,836 | | |
Accrued legal fees
|
| | | | — | | | | | | 71,724 | | |
Credit card liability
|
| | | | 71,757 | | | | | | 70,431 | | |
Accrued bonuses
|
| | | | 143,900 | | | | | | 5,400 | | |
Total accounts payable and accrued liabilities
|
| | | $ | 3,023,045 | | | | | $ | 2,806,228 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Loan payable – Automobile loan
|
| | | $ | 68,988 | | | | | $ | 52,188 | | |
Less current portion
|
| | | | (16,800) | | | | | | (17,095) | | |
Loan payable, net of current portion
|
| | | $ | 52,188 | | | | | $ | 35,093 | | |
Year ending December 31,
|
| |
Maturities of
Loan Payable |
| |||
2020
|
| | | $ | 17,095 | | |
2021
|
| | | | 17,394 | | |
2022
|
| | | | 17,699 | | |
| | | | $ | 52,188 | | |
| | |
Shares
|
| |
Weighted Average
Grant Date Fair Value |
| ||||||
Nonvested at December 31, 2018
|
| | | | — | | | | | | | | |
Granted
|
| | | | 555,403 | | | | | $ | 4.95 | | |
Vested
|
| | | | (327,422) | | | | | $ | (4.71) | | |
Forfeited
|
| | | | — | | | | | | — | | |
Nonvested at December 31, 2019
|
| | | | 227,981 | | | | | $ | 5.28 | | |
|
Annual dividend yield
|
| | | | — | | |
|
Expected life (years)
|
| | | | 5.5 | | |
|
Risk-free interest rate
|
| | | | 2.43% | | |
|
Expected volatility
|
| | | | 45.0% | | |
Components of total lease cost:
|
| |
Year ended
December 31, 2019 |
| |||
Operating lease expense
|
| | | $ | 104,794 | | |
Short-term lease expense
|
| | | | 38,414 | | |
Total lease cost
|
| | | $ | 143,208 | | |
|
| | |
As of
December 31, 2019 |
| |||
Assets | | | |||||
Lease right of use assets
|
| | | $ | 265,140 | | |
Total lease assets
|
| | | $ | 265,140 | | |
|
| | |
As of
December 31, 2019 |
| |||
Liabilities | | | |||||
Current liabilities: | | | |||||
Lease liability – current portion
|
| | | $ | 89,566 | | |
Noncurrent liabilities: | | | | | | | |
Lease liability, net of current portion
|
| | | | 177,578 | | |
Total lease liability
|
| | | $ | 267,144 | | |
|
Weighted average remaining lease term (in years) – operating leases
|
| | | | 4.51 | | |
|
Weighted average discount rate – operating leases
|
| | | | 8% | | |
Year ending December 31,
|
| |
Operating Leases
|
| |||
2020
|
| | | $ | 107,604 | | |
2021
|
| | | | 51,275 | | |
2022
|
| | | | 40,175 | | |
2023
|
| | | | 41,686 | | |
2024
|
| | | | 43,243 | | |
2025 and thereafter
|
| | | | 37,353 | | |
Total Minimum Lease Payments
|
| | | $ | 321,336 | | |
Less effects of discounting
|
| | | | (54,192) | | |
Present value of future minimum lease payments
|
| | | $ | 267,144 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Hometown Heroes Holdings, LLC
|
| | | $ | 601,729 | | | | | $ | — | | |
On Target Transactions LLC
|
| | | | 66,868 | | | | | | 2,561 | | |
Total due from affiliates
|
| | | $ | 668,597 | | | | | $ | 2,561 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Hometown Heroes Holdings, LLC
|
| | | $ | 10,064 | | | | | $ | 23,658 | | |
Total due to affiliates
|
| | | $ | 10,064 | | | | | $ | 23,658 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Current (provision) benefit: | | | | | | | | | | | | | |
Federal
|
| | | $ | — | | | | | $ | — | | |
State
|
| | | | (27,155) | | | | | | 8,000 | | |
Total Current
|
| | | | (27,155) | | | | | | 8,000 | | |
Deferred provision benefit: | | | | | | | | | | | | | |
Federal
|
| | | | — | | | | | | — | | |
State
|
| | | | — | | | | | | — | | |
Total deferred
|
| | | | — | | | | | | — | | |
Income tax (expense) benefit
|
| | | $ | (27,155) | | | | | $ | 8,000 | | |
| | |
Period/Year Ended
|
| |||||||||||||||||||||
| | |
12/31/2018
|
| |
12/31/2019
|
| ||||||||||||||||||
Provision for federal income taxes at statutory rates
|
| | | $ | 343,571 | | | | | | (21)% | | | | | $ | 861,062 | | | | | | (21)% | | |
Provision for state income taxes, net of federal benefit
|
| | | | 9,699 | | | | | | (1)% | | | | | | 79,435 | | | | | | (2)% | | |
Effect of flow-through entity
|
| | | | 2,542 | | | | | | 0% | | | | | | — | | | | | | 0% | | |
Change in valuation allowance
|
| | | | (410,754) | | | | | | 26% | | | | | | (926,681) | | | | | | 23% | | |
Nondeductible expenses
|
| | | | (698) | | | | | | 0% | | | | | | (7,437) | | | | | | 0% | | |
Tax effect of entities not included in consolidated return
|
| | | | 25,573 | | | | | | (2)% | | | | | | — | | | | | | 0% | | |
Return to provision adjustments
|
| | | | — | | | | | | 0% | | | | | | 2,172 | | | | | | 0% | | |
Other
|
| | | | 2,912 | | | | | | 0% | | | | | | (551) | | | | | | 0% | | |
Income tax (expense) benefit
|
| | | $ | (27,155) | | | | | | 2% | | | | | $ | 8,000 | | | | | | 0% | | |
Effective Tax Rate
|
| | | | 1.96% | | | | | | | | | | | | 0.20% | | | | | | | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Deferred tax assets | | | | | | | | | | | | | |
Net Operating Loss Carryforward
|
| | | $ | 484,058 | | | | | $ | 1,469,052 | | |
Property and equipment
|
| | | | 1,576 | | | | | | 430 | | |
Intangibles
|
| | | | 930 | | | | | | — | | |
Interest Expense Carryforward
|
| | | | 8,374 | | | | | | 33,741 | | |
Charitable Contributions Carryover
|
| | | | 322 | | | | | | 5,189 | | |
Other Accrued liabilities
|
| | | | — | | | | | | 457 | | |
Total deferred tax assets
|
| | | | 495,260 | | | | | | 1,508,869 | | |
Deferred tax liabilities | | | | | | | | | | | | | |
Internally Developed Software
|
| | | | (38,186) | | | | | | (105,869) | | |
Stock Compensation
|
| | | | — | | | | | | (19,093) | | |
Prepaid Expenses
|
| | | | (7,301) | | | | | | (7,453) | | |
Total deferred tax liabilities
|
| | | | (45,487) | | | | | | (132,415) | | |
Valuation Allowance
|
| | | | (449,773) | | | | | | (1,376,454) | | |
Deferred tax asset, net
|
| | | $ | — | | | | | $ | — | | |
| | |
December 31, 2019
|
| |
March 31, 2020
|
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
ASSETS
|
| | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 579,416 | | | | | $ | 844,449 | | |
Accounts receivable
|
| | | | 304,769 | | | | | | 743,193 | | |
Agent annual fees receivable, net of allowance of $349,420 and
$384,690 |
| | | | 356,131 | | | | | | 926,835 | | |
Due from affiliates
|
| | | | 2,561 | | | | | | 1,466 | | |
Prepaid and other current assets
|
| | | | 411,202 | | | | | | 452,048 | | |
Total current assets
|
| | | | 1,654,079 | | | | | | 2,967,991 | | |
Property and equipment, net
|
| | | | 105,972 | | | | | | 101,300 | | |
Capitalized software, net
|
| | | | 464,842 | | | | | | 567,057 | | |
Lease right of use assets
|
| | | | 265,140 | | | | | | 264,679 | | |
Total assets
|
| | | $ | 2,490,033 | | | | | $ | 3,901,027 | | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
| | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable and accrued liabilities
|
| | | $ | 2,806,228 | | | | | $ | 4,054,983 | | |
Due to affiliates
|
| | | | 23,658 | | | | | | 25,102 | | |
Loan payable – current portion
|
| | | | 17,095 | | | | | | 17,169 | | |
Lease liability – current portion
|
| | | | 89,566 | | | | | | 99,960 | | |
Total current liabilities
|
| | | | 2,936,547 | | | | | | 4,197,214 | | |
Loan payable, net of current portion
|
| | | | 35,093 | | | | | | 30,773 | | |
Note payable
|
| | | | 500,000 | | | | | | 500,000 | | |
Lease liability, net of current portion
|
| | | | 177,578 | | | | | | 167,261 | | |
Total liabilities
|
| | | | 3,649,218 | | | | | | 4,895,248 | | |
Commitments and contingencies | | | | | | | | | | | | | |
Stockholders’ Deficit: | | | | | | | | | | | | | |
Common stock, $0.00 par value, 100,000,000 authorized and
10,211,658 and 10,223,168 issued and outstanding as of December 31, 2019 and March 31, 2020 |
| | | | — | | | | | | — | | |
Additional paid-in capital
|
| | | | 4,988,382 | | | | | | 5,196,117 | | |
Accumulated deficit
|
| | | | (6,147,567) | | | | | | (6,190,338) | | |
Total stockholders’ deficit
|
| | | | (1,159,185) | | | | | | (994,221) | | |
Total liabilities and stockholders’ deficit
|
| | | $ | 2,490,033 | | | | | $ | 3,901,027 | | |
| | |
Three months ended March 31,
|
| |||||||||
| | |
2019
|
| |
2020
|
| ||||||
Revenue
|
| | | $ | 18,134,726 | | | | | $ | 28,838,831 | | |
Cost of revenue
|
| | | | 16,852,772 | | | | | | 26,687,256 | | |
Gross profit
|
| | | | 1,281,954 | | | | | | 2,151,575 | | |
General and administrative
|
| | | | 2,662,045 | | | | | | 1,930,076 | | |
Marketing
|
| | | | 57,762 | | | | | | 230,433 | | |
Total operating expenses
|
| | | | 2,719,807 | | | | | | 2,160,509 | | |
Loss from operations
|
| | | | (1,437,853) | | | | | | (8,934) | | |
Other expense, net | | | | | | | | | | | | | |
Interest expense, net
|
| | | | 27,370 | | | | | | 32,837 | | |
Other expense, net
|
| | | | 27,370 | | | | | | 32,837 | | |
Loss from operations before income taxes
|
| | | | (1,465,223) | | | | | | (41,771) | | |
Income tax expense
|
| | | | 4,020 | | | | | | 1,000 | | |
Net loss
|
| | | $ | (1,469,243) | | | | | $ | (42,771) | | |
Net loss per share | | | | | | | | | | | | | |
Basic and Diluted
|
| | | $ | (0.15) | | | | | $ | (0.00) | | |
Weighted average common shares outstanding | | | | | | | | | | | | | |
Basic and Diluted
|
| | | | 9,655,644 | | | | | | 9,993,866 | | |
| | |
Three months ended March 31, 2019
|
| |||||||||||||||||||||||||||
| | |
Common Stock
|
| |
Additional
Paid in Capital |
| |
Accumulated
deficit |
| |
Total
|
| ||||||||||||||||||
| | |
Shares
|
| |
Par Value
|
| ||||||||||||||||||||||||
Balance at December 31, 2018
|
| | | | 9,440,061 | | | | | $ | — | | | | | $ | 2,287,312 | | | | | $ | (2,055,270) | | | | | $ | 232,042 | | |
Issuance of common stock
|
| | | | 122,255 | | | | | | — | | | | | | 576,000 | | | | | | — | | | | | | 576,000 | | |
Share-based compensation
|
| | | | 193,081 | | | | | | — | | | | | | 910,092 | | | | | | — | | | | | | 910,092 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (1,469,243) | | | | | | (1,469,243) | | |
Balance at March 31, 2019
|
| | | | 9,755,397 | | | | | $ | — | | | | | $ | 3,773,404 | | | | | $ | (3,524,513) | | | | | $ | 248,891 | | |
|
| | |
Three months ended March 31, 2020
|
| |||||||||||||||||||||||||||
| | |
Common Stock
|
| |
Additional
Paid in Capital |
| |
Accumulated
deficit |
| |
Total
|
| ||||||||||||||||||
| | |
Shares
|
| |
Par Value
|
| ||||||||||||||||||||||||
Balance at December 31, 2019
|
| | | | 10,211,658 | | | | | $ | — | | | | | $ | 4,988,382 | | | | | $ | (6,147,567) | | | | | $ | (1,159,185) | | |
Issuance of common stock
|
| | | | 15,726 | | | | | | — | | | | | | 83,014 | | | | | | — | | | | | | 83,014 | | |
Share-based compensation
|
| | | | (4,216) | | | | | | — | | | | | | 124,721 | | | | | | — | | | | | | 124,721 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (42,771) | | | | | | (42,771) | | |
Balance at March 31, 2020
|
| | | | 10,223,168 | | | | | $ | — | | | | | $ | 5,196,117 | | | | | $ | (6,190,338) | | | | | $ | (994,221) | | |
| | |
Three months ended March 31,
|
| |||||||||
| | |
2019
|
| |
2020
|
| ||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (1,469,243) | | | | | $ | (42,771) | | |
Adjustments to reconcile net loss to net cash (used in) provided by operating
activities: |
| | | | | | | | | | | | |
Depreciation and amortization
|
| | | | 6,022 | | | | | | 19,275 | | |
Bad debt expense
|
| | | | 54,450 | | | | | | 35,270 | | |
Share-based compensation
|
| | | | 910,092 | | | | | | 124,721 | | |
Change in operating assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | 924,911 | | | | | | (438,424) | | |
Agent annual fees receivable
|
| | | | (251,905) | | | | | | (605,974) | | |
Due from affiliates
|
| | | | (25,679) | | | | | | 1,095 | | |
Prepaid and other assets
|
| | | | 3,299 | | | | | | (40,846) | | |
Accounts payable and accrued liabilities
|
| | | | (564,380) | | | | | | 1,248,755 | | |
Operating lease right of use assets
|
| | | | 21,129 | | | | | | 461 | | |
Operating lease liabilities
|
| | | | (20,641) | | | | | | 77 | | |
Due to affiliates
|
| | | | 1 | | | | | | 1,444 | | |
Net cash (used in) provided by operating activities
|
| | | | (411,944) | | | | | | 303,083 | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | | | |
Purchase of property and equipment
|
| | | | — | | | | | | (3,117) | | |
Purchase of capitalized software
|
| | | | (61,900) | | | | | | (113,701) | | |
Net cash used in investing activities
|
| | | | (61,900) | | | | | | (116,818) | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | | | |
Principal payments on loan payable
|
| | | | (4,173) | | | | | | (4,246) | | |
Proceeds from issuance of common stock
|
| | | | 576,000 | | | | | | 83,014 | | |
Net cash provided by financing activities
|
| | | | 571,827 | | | | | | 78,768 | | |
Net increase in cash and cash equivalents
|
| | | | 97,983 | | | | | | 265,033 | | |
Cash and cash equivalents at beginning of period
|
| | | | 1,008,538 | | | | | | 579,416 | | |
Cash and cash equivalents at end of period
|
| | | $ | 1,106,521 | | | | | $ | 844,449 | | |
Supplemental disclosure of cash and non-cash transactions: | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 27,394 | | | | | $ | 32,868 | | |
Income taxes paid
|
| | | $ | 12,505 | | | | | $ | 2,261 | | |
Right of use assets obtained in exchange for lease liabilities
|
| | | $ | 261,814 | | | | | $ | — | | |
Asset category
|
| |
Depreciable life
|
|
Vehicles | | |
7 years
|
|
Computers and equipment | | |
5 years
|
|
Furniture and fixtures | | |
7 years
|
|
| | |
March 31,
|
| |||||||||
| | |
2019
|
| |
2020
|
| ||||||
Shares issuable upon exercise of stock options
|
| | | | — | | | | | | 37,130 | | |
Non-vested shares under restricted stock grants
|
| | | | — | | | | | | 223,765 | | |
| | |
December 31,
2019 |
| |
March 31,
2020 |
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
Vehicles
|
| | | $ | 119,324 | | | | | $ | 119,324 | | |
Computers and equipment
|
| | | | 73,115 | | | | | | 76,232 | | |
Furniture and fixtures
|
| | | | 30,058 | | | | | | 30,058 | | |
Total property and equipment
|
| | | | 222,497 | | | | | | 225,614 | | |
Accumulated depreciation
|
| | | | (116,525) | | | | | | (124,314) | | |
Total property and equipment, net
|
| | | $ | 105,972 | | | | | $ | 101,300 | | |
| | |
December 31,
2019 |
| |
March 31,
2020 |
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
Software Development
|
| | | $ | 499,300 | | | | | $ | 613,000 | | |
Total capitalized software
|
| | | | 499,300 | | | | | | 613,000 | | |
Accumulated amortization
|
| | | | (34,458) | | | | | | (45,943) | | |
Total capitalized software, net
|
| | | $ | 464,842 | | | | | $ | 567,057 | | |
| | |
December 31,
2019 |
| |
March 31,
2020 |
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
Accounts payable
|
| | | $ | 922,373 | | | | | $ | 1,305,358 | | |
Deferred annual fee
|
| | | | 463,667 | | | | | | 1,122,266 | | |
Accrued professional fees
|
| | | | 601,797 | | | | | | 459,923 | | |
Accrued commissions
|
| | | | 261,161 | | | | | | 402,324 | | |
Accrued legal fees
|
| | | | 71,724 | | | | | | 190,160 | | |
Accrued compensation
|
| | | | 196,948 | | | | | | 188,236 | | |
Credit card liability
|
| | | | 70,431 | | | | | | 187,768 | | |
Other accrued liabilities
|
| | | | 72,836 | | | | | | 100,422 | | |
Insurance premium liabilities
|
| | | | 139,891 | | | | | | 89,326 | | |
Accrued bonuses
|
| | | | 5,400 | | | | | | 9,200 | | |
Total accounts payable and accrued liabilities
|
| | | $ | 2,806,228 | | | | | $ | 4,054,983 | | |
| | |
December 31,
2019 |
| |
March 31,
2020 |
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
Loan payable – Automobile loan
|
| | | $ | 52,188 | | | | | $ | 47,942 | | |
Less current portion
|
| | | | (17,095) | | | | | | (17,169) | | |
Loan payable, net of current portion
|
| | | $ | 35,093 | | | | | $ | 30,773 | | |
| | |
Shares
|
| |
Weighted
Average Grant Date Fair Value |
| ||||||
Nonvested at December 31, 2019
|
| | | | 227,981 | | | | | $ | 5.28 | | |
Granted
|
| | | | — | | | | | | — | | |
Vested
|
| | | | — | | | | | | — | | |
Forfeited
|
| | | | (4,216) | | | | | $ | (5.28) | | |
Nonvested at March 31, 2020
|
| | | | 223,765 | | | | | $ | 5.28 | | |
| | |
Three months ended March 31,
|
| |||||||||
Components of total lease cost:
|
| |
2019
|
| |
2020
|
| ||||||
| | |
(Unaudited)
|
| |||||||||
Operating lease expense
|
| | | $ | 27,228 | | | | | $ | 35,350 | | |
Short-term lease expense
|
| | | | 15,399 | | | | | | 17,003 | | |
Total lease cost
|
| | | $ | 42,627 | | | | | $ | 52,353 | | |
| | |
As of
March 31, 2020 |
| |||
| | |
(Unaudited)
|
| |||
Assets | | | | | | | |
Lease right of use assets
|
| | | $ | 264,679 | | |
Total lease assets
|
| | | $ | 264,679 | | |
Liabilities | | | | | | | |
Current liabilities: | | | | | | | |
Lease liability – current portion
|
| | | $ | 99,960 | | |
Noncurrent liabilities: | | | | | | | |
Lease liability, net of current portion
|
| | | | 167,261 | | |
Total lease liability
|
| | | $ | 267,221 | | |
|
Weighted average remaining lease term (in years) – operating leases . . . . . . . . . . . . . . . . .
|
| | | | 4.14 | | |
|
Weighted average discount rate – operating leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
| | | | 8% | | |
Year ending December 31,
|
| |
Operating
Leases |
| |||
2020 (remaining)
|
| | | | 103,180 | | |
2021
|
| | | | 51,275 | | |
2022
|
| | | | 40,175 | | |
2023
|
| | | | 41,686 | | |
2024
|
| | | | 43,243 | | |
2025 and thereafter
|
| | | | 37,353 | | |
Total Minimum Lease Payments
|
| | | $ | 316,912 | | |
Less effects of discounting
|
| | | | (49,691) | | |
Present value of future minimum lease payments
|
| | | $ | 267,221 | | |
| | |
December 31,
2019 |
| |
March 31,
2020 |
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
On Target Transactions LLC
|
| | | $ | 2,561 | | | | | $ | 1,466 | | |
Total due from affiliates
|
| | | $ | 2,561 | | | | | $ | 1,466 | | |
| | |
December 31,
2019 |
| |
March 31,
2020 |
| ||||||
| | | | | | | | |
(Unaudited)
|
| |||
Hometown Heroes Holdings, LLC
|
| | | $ | 23,658 | | | | | $ | 25,102 | | |
Total due to affiliates
|
| | | $ | 23,658 | | | | | $ | 25,102 | | |
Expense
|
| |
Amount Paid
or to be Paid |
| |||
SEC registration fee
|
| | | $ | 3,185 | | |
Financial Industry Regulatory Authority, Inc. Filing Fee
|
| | | $ | 2,600 | | |
Exchange Listing Fee
|
| | | $ | 45,000 | | |
Printing expenses
|
| | | $ | 60,000 | | |
Legal fees and expenses
|
| | | $ | 362,000 | | |
Transfer agent and registrar fees
|
| | | $ | 5,500 | | |
Accounting fees and expenses
|
| | | $ | 100,000 | | |
Miscellaneous expenses
|
| | | $ | 21,715 | | |
Total
|
| | | $ | 600,000 | | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Joshua Harley
Joshua Harley
|
| |
Chief Executive Officer, Director (Principal Executive Officer)
|
| |
July 16, 2020
|
|
|
/s/ Marco Fregenal
Marco Fregenal
|
| |
President and Chief Financial Officer, Director (Principal Financial Officer and Principal Accounting Officer)
|
| |
July 16, 2020
|
|
|
*
Chris Bennett
|
| |
Director
|
| |
July 16, 2020
|
|
|
*
Jeffrey H. Coats
|
| |
Director
|
| |
July 16, 2020
|
|
|
*
David C. Hood
|
| |
Director
|
| |
July 16, 2020
|
|
|
*
Glenn Sampson
|
| |
Director
|
| |
July 16, 2020
|
|
|
*
Jennifer B. Venable
|
| |
Director
|
| |
July 16, 2020
|
|
|
*By:
/s/ Marco Fregenal
Marco Fregenal,
as Attorney-in-Fact |
| | |
Exhibit 1.1
FATHOM HOLDINGS INC.
UNDERWRITING AGREEMENT
[●] Shares of Common Stock
________, 2020
Roth Capital Partners, LLC
888 San Clemente Drive, Suite 400
Newport Beach, CA 92660
Ladies and Gentlemen:
Fathom Holdings Inc., a North Carolina corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) [●] authorized but unissued shares (the “Firm Shares”) of common stock of the Company, no par value (the “Common Stock”). In addition, the Company and Glenn Sampson, its only selling shareholder (the “Selling Shareholder”), also propose to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional (i) [●] authorized but unissued shares of Common Stock (the “Company Option Shares”) and (ii) [●] issued and outstanding shares held by the Selling Stockholder (the “Secondary Shares” and, together with the Company Option Shares, the “Option Shares”). The Firm Shares, the Secondary Shares and the Company Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Underwriter Warrants (as defined below) and the Underwriter Warrant Shares (as defined below) are collectively referred to as the “Securities.”
The Company, the Selling Shareholder and the Underwriter hereby confirm their agreement as follows:
1. Registration Statement and Prospectus.
The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) a registration statement covering the Shares on Form S-1 (File No. 333-235972) under the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations (the “Rules and Regulations”) of the Commission thereunder, and such amendments to such registration statement (including post effective amendments) as may have been required to the date of this Agreement. Such registration statement, as amended (including any post effective amendments), has been declared effective by the Commission. Such registration statement, including amendments thereto at the time of effectiveness thereof (the “Effective Time”), the exhibits and any schedules thereto at the Effective Time or thereafter during the period of effectiveness and the documents and information otherwise deemed to be a part thereof or included therein by the Securities Act or otherwise pursuant to the Rules and Regulations at the Effective Time or thereafter during the period of effectiveness, including any post effective amendments, is herein called the “Registration Statement.” If the Company has filed or files an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the “Rule 462 Registration Statement”), then any reference herein to the term Registration Statement shall include such Rule 462 Registration Statement. Any preliminary prospectus included in the Registration Statement or filed with the Commission pursuant to Rule 424(a) under the Securities Act is hereinafter called a “Preliminary Prospectus.” The Preliminary Prospectus relating to the Shares that was included in the Registration Statement immediately prior to the pricing of the offering contemplated hereby is hereinafter called the “Pricing Prospectus.”
1
The Company is filing with the Commission pursuant to Rule 424 under the Securities Act a final prospectus covering the Shares, which includes the information permitted to be omitted therefrom at the Effective Time by Rule 430A under the Securities Act. Such final prospectus, as so filed, is hereinafter called the “Final Prospectus.” The Final Prospectus, the Pricing Prospectus and any preliminary prospectus in the form in which they were included in the Registration Statement or filed with the Commission pursuant to Rule 424 under the Securities Act is hereinafter called a “Prospectus.”
The Commission has not notified the Company of any objection to the use of form of Registration Statement or any post-effective amendment thereto.
2. Representations and Warranties of the Company Regarding the Offering.
(a) The Company represents and warrants to, and agrees with, the Underwriter, as of the date hereof, as of the Closing Date (as defined in Section 5(d) below) and as of each Option Closing Date (as defined in Section 5(b) below), as follows:
(i) No Material Misstatements or Omissions. At each of the time of effectiveness thereof, at the date hereof, at the Closing Date, and at each Option Closing Date, if any, the Registration Statement complied or will comply in all material respects with the requirements of the Securities Act and the Rules and Regulations and did not, does not, and will not, as the case may be, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Time of Sale Disclosure Package (as defined in Section 2(a)(v)(A)(1) below) as of [●] (Eastern time) (the “Applicable Time”) on the date hereof, at the Closing Date and on each Option Closing Date, if any, and the Final Prospectus, as amended or supplemented, as of its date, at the time of filing pursuant to Rule 424(b) under the Securities Act, at the Closing Date and at each Option Closing Date, if any, and any individual Written Testing-the-Waters Communication, when considered together with the Time of Sale Disclosure Package, did not, does not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the two immediately preceding sentences shall not apply to statements in or omissions from the Registration Statement, the Time of Sale Disclosure Package or any Prospectus in reliance upon, and in conformity with, written information furnished to the Company by the Underwriter specifically for use in the preparation thereof, which written information is described in Section 8(g). The Registration Statement contains all exhibits and schedules required to be filed by the Securities Act or the Rules and Regulations. No order preventing or suspending the effectiveness or use of the Registration Statement or any Prospectus is in effect and no proceedings for such purpose have been instituted or are pending, or, to the knowledge of the Company, are contemplated or threatened by the Commission.
2
(ii) Marketing Materials. The Company has not distributed any prospectus or other offering material in connection with the offering and sale of the Shares other than the Time of Sale Disclosure Package and the roadshow or investor presentations delivered to and approved by the Underwriter for use in connection with the marketing of the offering of the Securities (the “Marketing Materials”).
(iii) Emerging Growth Company. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act (an “Emerging Growth Company”).
(iv) Testing-the-Waters Communications. The Company (i) has not alone engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with the consent of the Underwriter with entities that are qualified institutional buyers within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and (ii) has not authorized anyone other than the Underwriter to engage in Testing-the-Waters Communications. The Company has not distributed any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Securities Act (“Written Testing-the-Waters Communications”), other than those previously provided to the Underwriter and listed on Schedule V hereto. “Testing-the-Waters Communication” means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act. Each Written Testing-the-Waters Communications, did not, as of the Applicable Time, and at all times through the completion of the public offer and sale of Shares will not, include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus.
(v) Accurate Disclosure. (A) The Company has provided a copy to the Underwriter of each Issuer Free Writing Prospectus (as defined below) used in the sale of Shares. The Company has filed all Issuer Free Writing Prospectuses required to be so filed with the Commission, and no order preventing or suspending the effectiveness or use of any Issuer Free Writing Prospectus is in effect and no proceedings for such purpose have been instituted or are pending, or, to the knowledge of the Company, are contemplated or threatened by the Commission. When taken together with the rest of the Time of Sale Disclosure Package or the Final Prospectus, no Issuer Free Writing Prospectus, as of its issue date and at all subsequent times though the completion of the public offer and sale of Shares, has, does or will include (x) any untrue statement of a material fact or omission to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or (y) information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Final Prospectus. The representations and warranties set forth in the immediately preceding sentence shall not apply to statements in or omissions from the Time of Sale Disclosure Package, the Final Prospectus or any Issuer Free Writing Prospectus in reliance upon, and in conformity with, written information furnished to the Company by the Underwriter specifically for use in the preparation thereof, which written information is described in Section 8(g). As used in this paragraph and elsewhere in this Agreement:
3
(1) “Time of Sale Disclosure Package” means the Prospectus most recently filed with the Commission before the time of this Agreement and each Issuer Free Writing Prospectus, and the description of the transaction provided by the Underwriter included on Schedule III.
(2) “Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 under the Securities Act, relating to the Shares that (A) is required to be filed with the Commission by the Company, or (B) is exempt from filing pursuant to Rule 433(d)(5)(i) or (d)(8) under the Securities Act, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g) under the Securities Act.
(B) At the time of filing of the Registration Statement and at the date hereof, the Company was not and is not an “ineligible issuer,” as defined in Rule 405 under the Securities Act or an “excluded issuer” as defined in Rule 164 under the Securities Act.
(C) Each Issuer Free Writing Prospectus listed on Schedule IV satisfied, as of its issue date and at all subsequent times through the Prospectus Delivery Period, all other conditions as may be applicable to its use as set forth in Rules 164 and 433 under the Securities Act, including any legend, record-keeping or other requirements.
(vi) Financial Statements. The financial statements of the Company, together with the related notes and schedules, included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission thereunder, and fairly present the financial condition of the Company as of the dates indicated and the results of operations and changes in cash flows for the periods therein specified in conformity with U.S. generally accepted accounting principles (“GAAP”) consistently applied throughout the periods involved. No other financial statements or schedules are required under the Securities Act, the Exchange Act, or the Rules and Regulations to be included in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus.
(vii) Independent Accountants. To the Company’s knowledge, BDO USA, LLP, which has expressed its opinion with respect to the financial statements and schedules included as a part of the Registration Statement and included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, is an independent public accounting firm with respect to the Company within the meaning of the Securities Act and the Rules and Regulations.
4
(viii) Accounting and Disclosure Controls. Except as disclosed in the Registration Statement, the Company and its Subsidiaries (as defined below) maintain systems of “internal control over financial reporting” (as defined under Rules 13a-15 and 15d-15 under the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus fairly present the information called for in all material respects and are prepared in accordance with the Commission’s rules and guidelines applicable thereto. Since the date of the latest audited financial statements included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, there has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. As used in this Agreement, the term “Subsidiaries” means Fathom Realty Holdings LLC and IntelliAgent, LLC (each a “Subsidiary”).
Except as disclosed in the Registration Statement, the Company maintains disclosure controls and procedures that have been designed to ensure that material information relating to the Company and its Subsidiaries is made known to the Company’s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective.
(ix) Forward-Looking Statements. The Company had a reasonable basis for, and made in good faith, each “forward-looking statement” (within the meaning of Section 27A of the Securities Act or Section 21E of the Exchange Act) contained or incorporated by reference in the Registration Statement, the Time of Sale Disclosure Package, the Final Prospectus or the Marketing Materials.
(x) Statistical and Marketing-Related Data. All statistical or market-related data included or incorporated by reference in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, or included in the Marketing Materials, are based on or derived from sources that the Company reasonably believes to be reliable and accurate, and the Company has obtained the written consent to the use of such data from such sources, to the extent required.
5
(xi) Trading Market. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and is approved for listing on the Nasdaq Capital Market (“Nasdaq”). To the Company’s knowledge, there is no action pending by Nasdaq to delist the Common Stock from Nasdaq, nor has the Company received any notification that Nasdaq is contemplating terminating such listing. When issued, the Shares and the Underwriter Warrant Shares will be listed on Nasdaq. The Company has taken all actions it deems reasonably necessary or advisable to take on or prior to the date of this Agreement to assure that it will be in compliance in all material respects with all applicable corporate governance requirements set forth in the rules of Nasdaq that are then in effect and will take all action it deems reasonably necessary or advisable to assure that it will be in compliance in all material respects with other applicable corporate governance requirements set forth in Nasdaq rules not currently in effect upon and all times after the effectiveness of such requirements.
(xii) Absence of Manipulation. The Company has not taken, directly or indirectly, any action that is designed to or that has constituted or that would reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.
(xiii) Investment Company Act. The Company is not and, after giving effect to the offering and sale of the Shares and the application of the net proceeds thereof, will not be an “investment company,” as such term is defined in the Investment Company Act of 1940, as amended.
3. Representations and Warranties Regarding the Company.
(a) The Company represents and warrants to, and agrees with, the Underwriter, as of the date hereof and as of the Closing Date and as of each Option Closing Date, as follows:
(i) Good Standing. Each of the Company and its Subsidiaries has been duly organized and is validly existing as a corporation or other entity in good standing under the laws of its jurisdiction of incorporation. Each of the Company and its Subsidiaries has the power and authority (corporate or otherwise) to own its properties and conduct its business as currently being carried on and as described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, and is duly qualified to do business as a foreign corporation or other entity in good standing in each jurisdiction in which it owns or leases real property or in which the conduct of its business makes such qualification necessary, except where the failure to so qualify would not have or be reasonably likely to result in a material adverse effect upon the business, prospects, properties, operations, condition (financial or otherwise) or results of operations of the Company and its Subsidiaries, taken as a whole, or in its ability to perform its obligations under this Agreement (“Material Adverse Effect”).
6
(ii) Authorization. The Company has the power and authority to enter into this Agreement and the Underwriter Warrants and to authorize, issue and sell the Shares, the Underwriter Warrants and the Underwriter Warrant Shares as contemplated by this Agreement and the Underwriter Warrants. This Agreement and the Underwriter Warrants have been duly authorized by the Company, and when executed and delivered by the Company, and will constitute the valid, legal and binding obligations of the Company, enforceable against the Company in accordance with its their respective terms, except as rights to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles of equity.
(iii) Contracts. The execution, delivery and performance of this Agreement, the Underwriter Warrants and the consummation of the transactions herein contemplated will not (A) result in a material breach or material violation of any of the terms and provisions of, or constitute a default under, any law, order, rule or regulation to which the Company or any Subsidiary is subject, or by which any property or asset of the Company or any Subsidiary is bound or affected, (B) conflict with, result in any material violation or material breach of, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) (a “Default Acceleration Event”) of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other instrument (the “Contracts”) or material obligation or other material understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, except to the extent that such conflict, default, or Default Acceleration Event not reasonably likely to result in a Material Adverse Effect, or (C) result in a breach or violation of any of the terms and provisions of, or constitute a default under, the Company’s articles of incorporation or by-laws.
(iv) No Violations of Governing Documents. Neither the Company nor any of its Subsidiaries is in violation, breach or default under its articles of incorporation, by-laws or other equivalent organizational or governing documents.
(v) Consents. No consents, approvals, orders, authorizations or filings are required on the part of the Company in connection with the execution, delivery or performance of this Agreement and the Underwriter Warrants and the issue and sale of the Shares, except (A) the registration under the Securities Act of the Shares, which has been effected, (B) the necessary filings and approvals from the Nasdaq to list the Shares and the Underwriter Warrant Shares, (C) such consents, approvals, authorizations, registrations or qualifications as may be required under state or foreign securities or Blue Sky laws and the rules of the Financial Industry Regulatory Authority, Inc. (“FINRA”) in connection with the purchase and distribution of the Shares by the Underwriter, (D) such consents and approvals as have been obtained and are in full force and effect, and (E) such consents, approvals, orders, authorizations and filings the failure of which to make or obtain is not reasonably likely to result in a Material Adverse Effect.
7
(vi) Capitalization. The Company has an authorized capitalization as set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. All of the issued and outstanding shares of capital stock of the Company are duly authorized and validly issued, fully paid and nonassessable, and have been issued in compliance with all applicable securities laws, and conform to the description thereof in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. All of the issued shares of capital stock of each Subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and, except as set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims. Except for the issuances of options or restricted stock in the ordinary course of business, since the respective dates as of which information is provided in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, the Company has not entered into or granted any convertible or exchangeable securities, options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company any shares of the capital stock of the Company. The Shares, when issued and paid for as provided herein, will be duly authorized and validly issued, fully paid and nonassessable, will be issued in compliance with all applicable securities laws, and will be free of preemptive, registration or similar rights and will conform to the description of the capital stock of the Company contained in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus. The shares of Common Stock issuable upon the exercise of the Underwriter Warrants (the “Underwriter Warrant Shares”), when issued, paid for and delivered upon due exercise of the Underwriter Warrants, as applicable, will be duly authorized and validly issued, fully paid and nonassessable, will be issued in compliance with all applicable securities laws, and will be free of preemptive, registration or similar rights. The Underwriter Warrant Shares have been reserved for issuance. The Underwriter Warrants, when issued, will conform in all material respects to the descriptions thereof set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus.
(vii) Taxes. Each of the Company and its Subsidiaries has (a) filed all foreign, federal, state and local tax returns (as hereinafter defined) required to be filed with taxing authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof and (b) paid all taxes (as hereinafter defined) shown as due and payable on such returns that were filed and has paid all taxes imposed on or assessed against the Company or such respective Subsidiary. The provisions for taxes payable, if any, shown on the financial statements included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements. To the knowledge of the Company, no issues have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from the Company or its Subsidiaries, and no waivers of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company or its Subsidiaries. The term “taxes” mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatever, together with any interest and any penalties, additions to tax, or additional amounts with respect thereto. The term “returns” means all returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.
8
(viii) Material Change. Since the respective dates as of which information is given in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, (a) neither the Company nor any of its Subsidiaries has incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of business, (b) the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock; (c) there has not been any change in the capital stock of the Company or any of its Subsidiaries (other than a change in the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise of outstanding options or warrants, upon the conversion of outstanding shares of preferred stock or other convertible securities or the issuance of restricted stock awards or restricted stock units under the Company’s existing stock awards plan, or any new grants thereof in the ordinary course of business), (d) there has not been any material change in the Company’s long-term or short-term debt, and (e) there has not been the occurrence of any Material Adverse Effect.
(ix) Absence of Proceedings. There is not pending or, to the knowledge of the Company, threatened, any action, suit or proceeding to which the Company or any of its Subsidiaries is a party or of which any property or assets of the Company or any of its Subsidiaries is the subject before or by any court or governmental agency, authority or body, or any arbitrator or mediator, which is reasonably likely to result in a Material Adverse Effect.
(x) Permits. The Company and each of its Subsidiaries holds, and is in compliance with, all franchises, grants, authorizations, licenses, permits, easements, consents, certificates and orders (“Permits”) of any governmental or self-regulatory agency, authority or body required for the conduct of its business, and all such Permits are in full force and effect, in each case except where the failure to hold, or comply with, any of them is not reasonably likely to result in a Material Adverse Effect or adversely affect the consummation of the transactions contemplated by this Agreement.
(xi) Good Title. The Company and each of its Subsidiaries have good and marketable title to all property (whether real or personal) described in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus as being owned by them that are material to the business of the Company, in each case free and clear of all liens, claims, security interests, other encumbrances or defects, except those that are disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus and those that are not reasonably likely to result in a Material Adverse Effect. The property held under lease by the Company and its Subsidiaries is held by them under valid, subsisting and enforceable leases with only such exceptions with respect to any particular lease as do not interfere in any material respect with the conduct of the business of the Company and its Subsidiaries.
9
(xii) Intellectual Property. The Company and each of its Subsidiaries owns or possesses or has valid right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights (“Intellectual Property”) necessary for the conduct of the business of the Company and its Subsidiaries as currently carried on and as described in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. To the knowledge of the Company, no action or use by the Company or any of its Subsidiaries involves or gives rise to any infringement of, or license or similar fees for, any Intellectual Property of others, except where such action, use, license or fee is not reasonably likely to result in a Material Adverse Effect. Neither the Company nor any of its Subsidiaries have received any notice alleging any such infringement or fee. To the Company’s knowledge, none of the technology employed by the Company or any Subsidiary has been obtained or is being used by the Company or such Subsidiary in violation of any contractual obligation binding on the Company or such Subsidiary or, to the Company’s knowledge, any of the officers, directors or employees of the Company or any Subsidiary, or, to the Company’s knowledge, otherwise in violation of the rights of any persons, except in each case for such violations as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(xiii) Employment Matters. There is (A) no unfair labor practice complaint pending against the Company, or any of its Subsidiaries, nor to the Company’s knowledge, threatened against it or any of its Subsidiaries, before the National Labor Relations Board, any state or local labor relation board or any foreign labor relations board, and no grievance or arbitration proceeding arising out of or under any collective bargaining agreement is so pending against the Company or any of its Subsidiaries, or, to the Company’s knowledge, threatened against it and (B) no labor disturbance by the employees of the Company or any of its Subsidiaries exists or, to the Company’s knowledge, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its Subsidiaries, principal suppliers, manufacturers, customers or contractors, that could reasonably be expected, singularly or in the aggregate, to have a Material Adverse Effect. The Company is not aware that any key employee or significant group of employees of the Company or any Subsidiary plans to terminate employment with the Company or any such Subsidiary.
(xiv) ERISA Compliance. No “prohibited transaction” (as defined in Section 406 of the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (“ERISA”), or Section 4975 of the Internal Revenue Code of 1986, as amended from time to time (the “Code”)) or “accumulated funding deficiency” (as defined in Section 302 of ERISA) or any of the events set forth in Section 4043(b) of ERISA (other than events with respect to which the thirty (30)-day notice requirement under Section 4043 of ERISA has been waived) has occurred or could reasonably be expected to occur with respect to any employee benefit plan of the Company or any of its Subsidiaries which would reasonably be expected to, singularly or in the aggregate, have a Material Adverse Effect. Each employee benefit plan of the Company or any of its Subsidiaries is in compliance in all material respects with applicable law, including ERISA and the Code. The Company and its Subsidiaries have not incurred and could not reasonably be expected to incur liability under Title IV of ERISA with respect to the termination of, or withdrawal from, any pension plan (as defined in ERISA). Each pension plan for which the Company or any of its Subsidiaries would have any liability that is intended to be qualified under Section 401(a) of the Code is so qualified, and, to the Company’s knowledge, nothing has occurred, whether by action or by failure to act, which could, singularly or in the aggregate, cause the loss of such qualification.
10
(xv) Environmental Matters. The Company and its Subsidiaries are in compliance with all foreign, federal, state and local rules, laws and regulations relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment which are applicable to their businesses (“Environmental Laws”), except where the failure to comply has not had and would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Effect. There has been no storage, generation, transportation, handling, treatment, disposal, discharge, emission, or other release of any kind of toxic or other wastes or other hazardous substances by, due to, or caused by the Company or any of its Subsidiaries (or, to the Company’s knowledge, any other entity for whose acts or omissions the Company or any of its Subsidiaries is or may otherwise be liable) upon any of the property now or previously owned or leased by the Company or any of its Subsidiaries, or upon any other property, in violation of any law, statute, ordinance, rule, regulation, order, judgment, decree or permit or which would, under any law, statute, ordinance, rule (including rule of common law), regulation, order, judgment, decree or permit, give rise to any liability, except for any violation or liability which has not had and would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Effect; and there has been no disposal, discharge, emission or other release of any kind onto such property or into the environment surrounding such property of any toxic or other wastes or other hazardous substances with respect to which the Company or any of its Subsidiaries has knowledge.
(xvi) SOX Compliance. The Company has taken all actions it deems reasonably necessary or advisable to take on or prior to the date of this Agreement to assure that, upon and at all times after the effectiveness of the Registration Statement, it will be in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) and all rules and regulations promulgated thereunder or implementing the provisions thereof that are then in effect and will take all action it deems reasonably necessary or advisable to assure that it will be in compliance in all material respects with other applicable provisions of the Sarbanes-Oxley Act not currently in effect upon it and at all times after the effectiveness of such provisions.
(xvii) Money Laundering Laws. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money Laundering Laws”); and no action, suit or proceeding by or before any Governmental Entity involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened. “Governmental Entity” shall be defined as any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency (whether foreign or domestic) having jurisdiction over the Company or any of its Subsidiaries or any of their respective properties, assets or operations.
11
(xviii) Foreign Corrupt Practices Act. Neither the Company, any of its Subsidiaries, nor any director or officer of the Company or any Subsidiary, nor, to the knowledge of the Company, any employee, representative, agent, affiliate of the Company or any of its Subsidiaries or any other person acting on behalf of the Company or any of its Subsidiaries, is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.
(xix) OFAC. Neither the Company, any of its Subsidiaries nor any director or officer of the Company or any Subsidiary, nor, to the knowledge of the Company, any employee, representative, agent or affiliate of the Company or any of its Subsidiaries or any other person acting on behalf of the Company or any of its Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the offering of the Shares contemplated hereby, or lend, contribute or otherwise make available such proceeds to any person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.
(xx) Insurance. The Company and each of its Subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as is adequate for the conduct of its business and the value of its properties and as is customary for companies engaged in similar businesses in similar industries.
(xxi) Books and Records. The minute books of the Company and each of its Subsidiaries have been made available to the Underwriter and counsel for the Underwriter, and such books (i) contain a complete summary of all meetings and actions of the board of directors (including each board committee) and shareholders of the Company (or analogous governing bodies and interest holders, as applicable), and each of its Subsidiaries since the time of its respective incorporation or organization through the date of the latest meeting and action, and (ii) accurately in all material respects reflect all transactions referred to in such minutes.
12
(xxii) No Undisclosed Contracts. There is no Contract or document required by the Securities Act or by the Rules and Regulations to be described in the Registration Statement, the Time of Sale Disclosure Package or in the Final Prospectus or to be filed as an exhibit to the Registration Statements which is not so described or filed therein as required; and all descriptions of any such Contracts or documents contained in the Registration Statement, the Time of Sale Disclosure Package and in the Final Prospectus are accurate and complete descriptions of such documents in all material respects. Other than as described in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, no such Contract has been suspended or terminated for convenience or default by the Company or any Subsidiary party thereto or any of the other parties thereto, and neither the Company nor any of its Subsidiaries has received notice, and the Company has no knowledge, of any such pending or threatened suspension or termination, except for such pending or threatened suspensions or terminations that have not had, and would not reasonably be expected to have, a Material Adverse Effect, individually or in the aggregate.
(xxiii) No Undisclosed Relationships. No relationship, direct or indirect, exists between or among the Company or any of its Subsidiaries on the one hand, and the directors, officers, shareholders (or analogous interest holders), customers or suppliers of the Company or any of its Subsidiaries on the other hand, which is required to be described in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus and which is not so described.
(xxiv) Insider Transactions. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company or any of its Subsidiaries to or for the benefit of any of the officers or directors of the Company, any of its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof, if and to the extent required under applicable law.
(xxv) No Registration Rights. No person or entity has the right to require registration of Common Shares or other securities of the Company or any of its Subsidiaries within 180 days of the date hereof because of the filing or effectiveness of the Registration Statement or otherwise, except for persons and entities who have expressly waived such right in writing or who have been given timely and proper written notice and have failed to exercise such right within the time or times required under the terms and conditions of such right. Except as described in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, there are no persons with registration rights or similar rights to have any securities registered by the Company or any of its Subsidiaries under the Securities Act.
13
(xxvi) Continued Business. No supplier, customer, distributor or sales agent of the Company or any Subsidiary has notified the Company or any Subsidiary that it intends to discontinue or decrease the rate of business done with the Company or any Subsidiary, except where such discontinuation or decrease has not resulted in and could not reasonably be expected to result in a Material Adverse Effect.
(xxvii) No Finder’s Fee. There are no claims, payments, issuances, arrangements or understandings for services in the nature of a finder’s, consulting or origination fee with respect to the introduction of the Company to the Underwriter or the sale of the Shares hereunder or any other arrangements, agreements, understandings, payments or issuances with respect to the Company that may affect the Underwriter’s compensation, as determined by FINRA.
(xxviii) No Fees. Except as disclosed to the Underwriter in writing, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to (i) any person, as a finder’s fee, investing fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who provided capital to the Company, (ii) any FINRA member, or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member within the 12-month period prior to the date on which the Registration Statement was filed with the Commission (“Filing Date”) or thereafter.
(xxix) Proceeds. None of the net proceeds of the offering will be paid by the Company to any participating FINRA member or any affiliate or associate of any participating FINRA member, except as specifically authorized herein.
(xxx) No FINRA Affiliations. To the Company’s knowledge, no (i) officer or director of the Company or its Subsidiaries, (ii) owner of 5% or more of any class of the Company’s securities or (iii) owner of any amount of the Company’s unregistered securities acquired within the 180-day period prior to the Filing Date, has any direct or indirect affiliation or association with any FINRA member. The Company will advise the Underwriter and counsel to the Underwriter if it becomes aware that any officer, director of the Company or its Subsidiaries or any owner of 5% or more of any class of the Company’s securities is or becomes an affiliate or associated person of a FINRA member participating in the offering.
(xxxi) No Financial Advisor. Other than the Underwriter, no person has the right to act as an underwriter or as a financial advisor to the Company in connection with the transactions contemplated hereby.
(xxxii) Certain Statements. The statements set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, insofar as they purport to describe the provisions of the laws and documents referred to therein, are accurate, complete and fair in all material respects, and under the caption “Description of Securities” insofar as they purport to constitute a summary of (i) the terms of the Company’s outstanding securities, (ii) the terms of the Shares, and (iii) the terms of the documents referred to therein, are accurate, complete and fair in all material respects.
14
(xxxiii) Prior Sales of Securities. Except as set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, the Company has not sold or issued any shares of Common Stock during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulations D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans, stock option plans or other employee compensation plans or pursuant to outstanding preferred stock, options, rights or warrants or other outstanding convertible securities.
(b) Any certificate signed by any officer of the Company and delivered to the Underwriter or to counsel for the Underwriter shall be deemed a representation and warranty by the Company to the Underwriter as to the matters covered thereby.
4. Representations and Warranties of the Selling Shareholder.
(a) The Selling Shareholder represents and warrants to, and agrees with, the Underwriter as follows:
(i) Due Authorization. This Agreement has been duly authorized, executed and delivered by such Selling Shareholder, and constitutes a valid, legal and binding obligation of such Selling Shareholder, enforceable in accordance with its terms, except as rights to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles of equity. The execution, delivery and performance of this Agreement and the consummation of the transactions herein contemplated will not result in a breach or violation of any of the terms and provisions of, or constitute a default under, any statute, agreement or instrument to which the Selling Shareholder is a party or by which it is bound or to which any of its property is subject, or any order, rule, regulation or decree of any court or governmental agency or body having jurisdiction over the Selling Shareholder or any of its properties, except for violations and defaults that individually or in the aggregate would not reasonably be expected to have a Material Adverse Effect. No consent, approval, authorization or order of, or filing with, any court or governmental agency or body is required for the execution, delivery and performance of this Agreement or for the consummation of the transactions contemplated hereby, including the sale of the Shares by the Selling Shareholder, except as may be required under the Securities Act or state securities or blue sky laws; and the Selling Shareholder has the power and authority to enter into this Agreement and to sell the Shares as contemplated by this Agreement.
(ii) Record Holder. Such Selling Shareholder is, on the date hereof, the record and beneficial owner of all of the Shares to be sold by the Selling Shareholder hereunder free and clear of all liens, encumbrances, equities and claims.
15
(iii) Taxes. On the applicable Closing Date, all stock transfer or other taxes (other than income taxes) that are required to be paid in connection with the sale and transfer by such Selling Shareholder of the Shares will be fully paid or provided for by such Selling Shareholder and all laws imposing such taxes will be fully complied with.
(iv) Compliance. All information with respect to such Selling Shareholder contained in the Registration Statement, the Time of Sale Disclosure Package and any Prospectus, or any amendment or supplement thereto, complied or will comply in all material respects with all applicable requirements of the Securities Act and the Rules and Regulations promulgated thereunder and does not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading.
(v) No Transfer of Shares. Such Selling Shareholder, directly or indirectly, has not entered into any commitment, transaction or other arrangement, including any prepaid forward contract, 10b5-1 plan or similar agreement, which transfers or may transfer any of the legal or beneficial ownership or any of the economic consequences of ownership of the Shares, except as has been previously disclosed in writing to the Underwriter.
(vi) No Free Writing Prospectus. Such Selling Shareholder represents and warrants that it has not prepared or had prepared on its behalf or used or referred to any “free writing prospectus” (as defined in Rule 405 of the Act) and further represents that it has not distributed and will not distribute any written materials in connection with the offer or sale of the Shares that could otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Act) required to be filed with the Commission or retained under Rule 433 of the Act.
(vii) Accurate Information. All information relating to such Selling Shareholder furnished by or on behalf of such Selling Shareholder in writing expressly for use in the Registration Statement, the Time of Sale Disclosure Package or any Prospectus, as the case may be, is as of the applicable Closing Date, true, correct, and complete in all material respects, and does not, and will not, contain any untrue statement of a material fact or omit to state any material fact necessary to make such information not misleading in light of the circumstances under which such information was furnished. In addition, such Selling Shareholder confirms as accurate the number of shares of Common Stock set forth opposite such Selling Shareholder’s name in the Time of Sale Disclosure Package and any Prospectus under the caption “Selling Shareholder” (both prior to and after giving effect to the sale of the Shares).
(viii) No Restrictions. Such Selling Shareholder does not have any registration or other similar rights to have any equity or debt securities registered for sale by the Company under the Registration Statement or included in an offering contemplated by this Agreement, except for such rights that have been waived.
(ix) Absence of Manipulation. Such Selling Shareholder has not taken and will not take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.
16
(x) Accuracy of Representations and Warranties. Nothing has come to the attention of such Selling Shareholder that has caused such Selling Shareholder to believe that the representations and warranties of the Company contained in this Section are not true and correct; such Selling Shareholder has reviewed the Registration Statement, the Time of Sale Disclosure Package and each Prospectus and has no knowledge of any material fact, condition or information not disclosed in the Registration Statement, the Time of Sale Disclosure Package or such Prospectus which has had or which could reasonably be expected to result in a Material Adverse Effect, and such Selling Shareholder is not prompted to sell shares of Common Stock by any information concerning the Company that is not set forth in the Registration Statement, the Time of Sale Disclosure Package or a Prospectus.
5. Purchase, Sale and Delivery of Shares.
(a) On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth, the Company agrees to issue and sell the Firm Shares, and the Underwriter agrees to purchase the Firm Shares set forth opposite the name of the Underwriter in Schedule I hereto. The combined purchase price to be paid by the Underwriters to the Company for the Firm Shares shall be $[●] per share and related Underwriter Warrant.
(b) The Company and the Selling Shareholder hereby grant to the Underwriter the option to purchase some or all of the Company Option Shares and the Secondary Shares and, upon the basis of the warranties and representations and subject to the terms and conditions herein set forth, the Underwriter shall have the right to purchase all or any portion of the Company Option Shares and the Secondary Shares as may be necessary to cover over-allotments made in connection with the transactions contemplated hereby. The purchase price to be paid by the Underwriters for the Option Shares shall be $[ ] per share. This option may be exercised by the Underwriter at any time and from time to time on or before the forty-fifth (45th) day following the date hereof, by written notice to the Company and the Selling Shareholder (the “Option Notice”). The Option Notice shall set forth the aggregate number of Option Shares as to which the option is being exercised, and the date and time when the Option Shares are to be delivered (such date and time being herein referred to as the “Option Closing Date”); provided, however, that the Option Closing Date shall not be earlier than the Closing Date (as defined below) nor earlier than the first business day after the date on which the option shall have been exercised nor later than the fifth business day after the date on which the option shall have been exercised unless the Company and the Underwriter otherwise agree. If the Underwriter elects to purchase less than all of the Option Shares, the Company and the Selling Shareholder agree that the Selling Shareholder will sell to the Underwriter the full amount of the Secondary Shares offered before the Company may sell any other Option Shares offered by the Company.
(c) Payment of the purchase price for and delivery of the Option Shares shall be made on an Option Closing Date in the same manner and at the same office as the payment for the Firm Shares, as set forth in subparagraph (d) below.
17
(d) The Firm Shares will be delivered by the Company to the Underwriter, against payment of the purchase price therefor by wire transfer of same day funds payable to the order of the Company at the offices of Roth Capital Partners, LLC, 888 San Clemente Drive, Suite 400, Newport Beach, CA 92660, or such other location as may be mutually acceptable, at 6:00 a.m. Pacific Time, on the second (or if the Firm Shares are priced, as contemplated by Rule 15c6-1(c) under the Exchange Act, after 4:30 p.m. Eastern time, the third) full business day following the date hereof, or at such other time and date as the Underwriter and the Company determine pursuant to Rule 15c6-1(a) under the Exchange Act, or, in the case of the Option Shares, at such date and time set forth in the Option Notice. The time and date of delivery of the Firm Shares is referred to herein as the “Closing Date.” On the Closing Date, the Company shall deliver the Firm Shares, which shall be registered in the name or names and shall be in such denominations as the Underwriter may request at least one (1) business day before the Closing Date, to the account of the Underwriter, which delivery shall be made through the facilities of the Depository Trust Company’s DWAC system.
(e) It is understood that the Representative has been authorized to accept delivery of and receipt for, and make payment of the purchase price for, the Firm Shares and any Company Option Shares or Secondary Shares that the Underwriter has agreed to purchase. The Representative, individually and not as the Representative of the Underwriters, may (but shall not be obligated to) make payment for any Shares to be purchased by the Underwriter whose funds shall not have been received by the Representative by the Closing Date or any Option Closing Date, as the case may be, for the account of the Underwriter, but any such payment shall not relieve the Underwriter from any of its obligations under this Agreement.
(f) On the Closing Date, the Company shall issue to the Underwriter (and/or it’s designee(s)), warrants (the “Underwriter Warrants”), in form and substance acceptable to the Underwriter, for the purchase of an aggregate of [●] shares of Common Stock, which shall be registered in the name or names and shall be in such denominations as Underwriter may request at least one (1) business day before the Closing Date.
6. Covenants.
(a) The Company covenants and agrees with the Underwriter as follows:
(i) The Company shall prepare the Final Prospectus in a form approved by the Underwriter and file such Final Prospectus pursuant to Rule 424(b) under the Securities Act not later than the Commission's close of business on the second business day following the execution and delivery of this Agreement, or, if applicable, such earlier time as may be required by the Rules and Regulations.
(ii) During the period beginning on the date hereof and ending on the later of the Closing Date or such date as determined by the Underwriter the Final Prospectus is no longer required by law to be delivered in connection with sales by an underwriter or dealer (the “Prospectus Delivery Period”), prior to amending or supplementing the Registration Statement, including any Rule 462 Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, the Company shall furnish to the Underwriter for review and comment a copy of each such proposed amendment or supplement, and the Company shall not file any such proposed amendment or supplement to which the Underwriter reasonably objects.
18
(iii) From the date of this Agreement until the end of the Prospectus Delivery Period, the Company shall promptly advise the Underwriter in writing (A) of the receipt of any comments of, or requests for additional or supplemental information from, the Commission, (B) of the time and date of any filing of any post-effective amendment to the Registration Statement or any amendment or supplement to the Time of Sale Disclosure Package, the Final Prospectus or any Issuer Free Writing Prospectus, (C) of the time and date that any post-effective amendment to the Registration Statement becomes effective and (D) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any order preventing or suspending its use or the use of the Time of Sale Disclosure Package, the Final Prospectus or any Issuer Free Writing Prospectus, or of any proceedings to remove, suspend or terminate from listing or quotation the Common Stock from any securities exchange upon which it is listed for trading or included or designated for quotation, or of the threatening or initiation of any proceedings for any of such purposes. If the Commission shall enter any such stop order at any time during the Prospectus Delivery Period, the Company will use its reasonable efforts to obtain the lifting of such order at the earliest possible moment. Additionally, the Company agrees that it shall comply with the provisions of Rules 424(b), 430A or 430C as applicable, under the Securities Act and will use its reasonable efforts to confirm that any filings made by the Company under Rule 424(b) or Rule 433 were received in a timely manner by the Commission (without reliance on Rule 424(b)(8) or 164(b) of the Securities Act).
(iv) (A) During the Prospectus Delivery Period, the Company will comply with all requirements imposed upon it by the Securities Act, as now and hereafter amended, and by the Rules and Regulations, as from time to time in force, and by the Exchange Act, as now and hereafter amended, so far as necessary to permit the continuance of sales of or dealings in the Shares as contemplated by the provisions hereof, the Time of Sale Disclosure Package, the Registration Statement and the Final Prospectus. If during the Prospectus Delivery Period any event occurs the result of which would cause the Final Prospectus (or if the Final Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package ) to include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary or appropriate in the opinion of the Company or its counsel or the Underwriter or counsel to the Underwriter to amend the Registration Statement or supplement the Final Prospectus (or if the Final Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package ) to comply with the Securities Act, the Company will promptly notify the Underwriter, allow the Underwriter the opportunity to provide reasonable comments on such amendment, prospectus supplement or document, and will amend the Registration Statement or supplement the Final Prospectus (or if the Final Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package) or file such document (at the expense of the Company) so as to correct such statement or omission or effect such compliance.
19
(B) If at any time during the Prospectus Delivery Period there occurred or occurs an event or development the result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement or any Prospectus or included or would include, when taken together with the Time of Sale Disclosure Package, an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Underwriter and will promptly amended or will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.
(v) The Company shall take or cause to be taken all necessary action to qualify the Shares for sale under the securities laws of such jurisdictions as the Underwriter reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Shares, except that the Company shall not be required in connection therewith to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified, to execute a general consent to service of process in any state or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise subject.
(vi) The Company will furnish to the Underwriter and counsel to the Underwriter copies of the Registration Statement, each Prospectus, any Issuer Free Writing Prospectus, and all amendments and supplements to such documents, in each case as soon as available and in such quantities as the Underwriter may from time to time reasonably request.
(vii) The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after the end of the Company’s current fiscal quarter, an earnings statement (which need not be audited) covering a 12-month period that shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 of the Rules and Regulations.
(viii) The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay or cause to be paid (A) all expenses (including transfer taxes allocated to the respective transferees) incurred in connection with the delivery to the Underwriter of the Shares (including all fees and expenses of the registrar and transfer agent of the Shares and the registrar and transfer agent of the Underwriter Warrants (if other than the Company), and the cost of preparing and printing stock certificates and warrant certificates), (B) all reasonable expenses and reasonable fees (including, without limitation, the reasonable fees and reasonable expenses of the Company’s counsel) in connection with the preparation, printing, filing, delivery, and shipping of the Registration Statement (including the financial statements therein and all amendments, schedules, and exhibits thereto), the Shares, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus, any Issuer Free Writing Prospectus and any amendment thereof or supplement thereto, (C) all reasonable filing fees and reasonable fees and disbursements of the Underwriter’s counsel incurred in connection with the qualification of the Shares for offering and sale by the Underwriter or by dealers under the securities or blue sky laws of the states and other jurisdictions that the Underwriter shall designate, (D) the reasonable filing fees and reasonable fees and disbursements of counsel to the Underwriter incident to any required review and approval by FINRA, of the terms of the sale of the Shares, (F) listing fees, if any, and (G) all other reasonable costs and reasonable expenses incident to the performance of its obligations hereunder that are not otherwise specifically provided for herein. The Company will reimburse the Representative for the Underwriters’ reasonable out-of-pocket expenses, including legal fees and disbursements, in connection with the purchase and sale of the Shares contemplated hereby up to an aggregate of $150,000 (including amounts payable pursuant to clauses (C) and (D) above); without the Company’s prior written consent, such consent not to be unreasonably withheld. If this Agreement is terminated by the Underwriter in accordance with the provisions of Section 7, Section 10 or Section 12, the Company will reimburse the Underwriter for all out-of-pocket disbursements (including, but not limited to, reasonable fees and disbursements of counsel, travel expenses, postage, facsimile and telephone charges) incurred by the Underwriter in connection with its investigation, preparing to market and marketing the Shares or in contemplation of performing its obligations hereunder.
20
(ix) The Company intends to apply the net proceeds from the sale of the Shares to be sold by it hereunder for the purposes set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus under the heading “Use of Proceeds”.
(x) The Company has not taken and will not take, directly or indirectly, during the Prospectus Delivery Period, any action designed to or which might reasonably be expected to cause or result in, or that has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.
(xi) The Company represents and agrees that, unless it obtains the prior written consent of the Underwriter represents and agrees that, unless it obtains the prior written consent of the Company, it has not made and will not make any offer relating to the Shares that would constitute an Issuer Free Writing Prospectus; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the free writing prospectuses included in Schedule IV. Any such free writing prospectus consented to by the Company and the Underwriter is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents that it has treated or agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied or will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely Commission filing where required, legending and record-keeping.
21
(xii) The Company hereby agrees that, without the prior written consent of the Underwriter, it will not, during the period ending one hundred and eight (180) days after the date hereof (“Lock-Up Period”), (i) offer, pledge, issue, sell, contract to sell, purchase, contract to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock; or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise; or (iii) file any registration statement with the Commission relating to the offering of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock. The restrictions contained in the preceding sentence shall not apply to (1) the Shares to be sold hereunder, (2) the issuance of Common Stock upon the exercise of options or warrants or the conversion of outstanding preferred stock or other outstanding convertible securities disclosed as outstanding in the Registration Statement (excluding exhibits thereto), the Time of Sale Disclosure Package, and the Final Prospectus, (3) the issuance of employee stock options not exercisable during the Lock-Up Period and the grant of restricted stock awards or restricted stock units or shares of Common Stock pursuant to equity incentive plans described in the Registration Statement (excluding exhibits thereto), the Time of Sale Disclosure Package, and the Final Prospectus (collectively, “Incentive Equity”), or (4) the filing of a registration statement on Form S-8 covering Incentive Equity.
(xiii) The Company hereby agrees, during a period of three years from the effective date of the Registration Statement, to furnish to the Underwriter copies of all reports or other communications (financial or other) furnished to shareholders, and to deliver to the Underwriter as soon as reasonably practicable upon availability, copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange on which any class of securities of the Company is listed; provided, that any information or documents available on the Commission’s Electronic Data Gathering, Analysis and Retrieval System shall be considered furnished for purposes of this Section 5(a)(xiii).
(xiv) The Company hereby agrees to engage and maintain, at its expense, a registrar and transfer agent for the Common Stock.
(xv) The Company hereby agrees to use its reasonable best efforts to obtain approval to list the Shares and the Underwriter Warrant Shares on Nasdaq.
(xvi) The Company hereby agrees not to take, directly or indirectly, any action designed to cause or result in, or that has constituted or might reasonably be expected to constitute, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any securities of the Company to facilitate the sale or resale of the Shares.
(xvii) The Company will promptly notify the Underwriter if the Company ceases to be an Emerging Growth Company at any time prior to the later of (a) the end of the Prospectus Delivery Period and (b) the expiration of the lock-up period described in Section 7(xii) above.
(b) The Selling Shareholder covenants and agrees with the Underwriter as follows:
22
(i) The Selling Shareholder, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay or cause to be paid, all expenses (including transfer taxes allocated to the respective transferees) incurred by him in connection with the delivery to the Underwriter of the Secondary Shares to be sold by the Selling Shareholder hereunder.
(ii) Such Selling Shareholder will deliver to the Underwriter prior to the applicable Closing Date a properly completed and executed United States Treasury Department Form W-9.
(iii) During the Prospectus Delivery Period, such Selling Shareholder will advise the Underwriter promptly, and if requested by the Underwriter, will confirm such advice in writing, of any change in information relating to such Selling Shareholder in the Registration Statement, the Time of Sale Disclosure Package or any Prospectus.
(iv) Such Selling Shareholder agrees that it will not prepare or have prepared on its behalf or use or refer to any "free writing prospectus" (as such term is defined in Rule 405 under the Act), and agrees that it will not distribute any written materials in connection with the offer or sale of the Shares.
7. Conditions of the Underwriter’s Obligations. The obligations of the Underwriter hereunder to purchase the Shares are subject to the accuracy, as of the date hereof and at all times through the Closing Date, and on each Option Closing Date (as if made on the Closing Date or such Option Closing Date, as applicable), of and compliance with all representations, warranties and agreements of the Company and the Selling Shareholder contained herein, the performance by the Company and the Selling Shareholder of their obligations hereunder and the following additional conditions:
(a) If filing of the Final Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, is required under the Securities Act or the Rules and Regulations, the Company shall have filed the Final Prospectus (or such amendment or supplement) or such Issuer Free Writing Prospectus with the Commission in the manner and within the time period so required (without reliance on Rule 424(b)(8) or 164(b) under the Securities Act); the Registration Statement shall remain effective; no stop order suspending the effectiveness of the Registration Statement or any part thereof, any Rule 462 Registration Statement, or any amendment thereof, nor suspending or preventing the use of the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus shall have been issued; no proceedings for the issuance of such an order shall have been initiated or threatened by the Commission; any request of the Commission or the Underwriter for additional information (to be included in the Registration Statement, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus, any Issuer Free Writing Prospectus or otherwise) shall have been complied with to the satisfaction of the Underwriter.
(b) The Shares and the Underwriter Warrant Shares shall be approved for listing on Nasdaq, subject to official notice of issuance and evidence of satisfactory distribution.
23
(c) FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements.
(d) The Underwriter shall not have reasonably determined, and advised the Company, that the Registration Statement, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus, or any amendment thereof or supplement thereto, or any Issuer Free Writing Prospectus, contains an untrue statement of fact which, in the reasonable opinion of the Underwriter, is material, or omits to state a fact which, in the reasonable opinion of the Underwriter, is material and is required to be stated therein or necessary to make the statements therein not misleading.
(e) On or after the date hereof (i) no downgrading shall have occurred in the rating accorded any of the Company’s securities by any “nationally recognized statistical organization,” as that term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act, and (ii) no such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the Company’s securities.
(f) On the Closing Date and on each Option Closing Date, there shall have been furnished to the Underwriter the opinion and negative assurance letters of Wyrick Robbins Yates & Ponton LLP, counsel to the Company, each dated the Closing Date or the Option Closing Date, as applicable, and addressed to the Underwriter, in form and substance reasonably satisfactory to the Underwriter, to the effect set forth in Exhibit C.
(g) On the Closing Date and on each Option Closing Date, there shall have been furnished to the Underwriter the negative assurance letter of Pryor Cashman LLP, counsel to the Underwriters, dated the Closing Date or the Option Closing Date, as applicable, and addressed to the Underwriter, in form and substance reasonably satisfactory to Underwriter.
(h) On each Option Closing Date on which the Selling Shareholder is selling Secondary Shares hereunder, there shall have been furnished to the Underwriter the opinion of Wyrick Robbins Yates & Ponton LLP, as special legal counsel to the Selling Shareholder, dated the Closing Date or the Option Closing Date, as applicable, and addressed to the Underwriter, in form and substance reasonably satisfactory to the Underwriter, to the effect set forth in Exhibit D.
(i) The Underwriter shall have received a letter of BDO USA, LLP, on the date hereof and on the Closing Date and on each Option Closing Date, addressed to the Underwriter, confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating to the qualifications of accountants under Rule 2-01 of Regulation S-X of the Commission, and confirming, as of the date of each such letter (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, as of a date not prior to the date hereof or more than five days prior to the date of such letter), the conclusions and findings of said firm with respect to the financial information and other matters required by the Underwriter.
24
(j) On the Closing Date and on each Option Closing Date, there shall have been furnished to the Underwriter a certificate, dated the Closing Date and on each Option Closing Date and addressed to the Underwriter, signed by the chief executive officer and the chief financial officer of the Company, in their capacity as officers of the Company, to the effect that:
(i) The representations and warranties of the Company in this Agreement that are qualified by materiality or by reference to any Material Adverse Effect are true and correct in all respects, and all other representations and warranties of the Company in this Agreement are true and correct, in all material respects, as if made at and as of the Closing Date and on the Option Closing Date, and the Company has complied in all material respects with all the agreements and satisfied all the conditions on its part required to be performed or satisfied at or prior to the Closing Date or on the Option Closing Date, as applicable;
(ii) No stop order or other order (A) suspending the effectiveness of the Registration Statement or any part thereof or any amendment thereof, (B) suspending the qualification of the Shares for offering or sale, or (C) suspending or preventing the use of the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus, has been issued, and no proceeding for that purpose has been instituted or, to their knowledge, is contemplated by the Commission or any state or regulatory body; and
(iii) There has been no occurrence of any event resulting or reasonably likely to result in a Material Adverse Effect during the period from and after the date of this Agreement and prior to the Closing Date or on the Option Closing Date, as applicable.
(k) On each Option Closing Date on which the Selling Shareholder is selling Secondary Shares hereunder, there shall have been furnished to the Underwriter certificates, dated the Option Closing Date and addressed to the Underwriter, signed by the Selling Shareholder, to the effect that the representations and warranties of such Selling Shareholder in this Agreement are true and correct, in all material respects, as if made at and as of the Option Closing Date, as applicable, and such Selling Shareholder has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to the Option Closing Date.
(l) On or before the date hereof, the Underwriter shall have received duly executed lock-up agreement (each a “Lock-Up Agreement”) in the form set forth on Exhibit A hereto, by and between the Underwriter and each of the parties specified in Schedule VI.
If the Underwriter, in its sole discretion, agrees to release or waive the restrictions set forth in the Lock-Up Agreement for an officer or director of the Company and provides the Company with notice of the impending release or waiver at least three business days before the effective date of the release or waiver, the Company agrees to announce the impending release or waiver by a press release substantially in the form of Exhibit B hereto through a major news service at least two business days before the effective date of the release or waiver.
25
(m) The Company and the Selling Shareholder shall have furnished to the Underwriter and its counsel such additional documents, certificates and evidence as the Underwriter or its counsel may have reasonably requested.
If any condition specified in this Section 7 shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Underwriter by notice to the Company and the Selling Shareholder at any time at or prior to the Closing Date or on the Option Closing Date, as applicable, and such termination shall be without liability of any party to any other party, except that Section 6(a)(viii), Section 10 and Section 11 shall survive any such termination and remain in full force and effect.
8. Indemnification and Contribution.
(a) The Company agrees to indemnify, defend and hold harmless the Underwriter, its affiliates, directors and officers and employees, and each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any losses, claims, damages or liabilities to which such party may become subject, under the Securities Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Company), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, including the information deemed to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Rules and Regulations, or arise out of or are based upon the omission from the Registration Statement, or alleged omission to state therein, a material fact required to be stated therein or necessary to make the statements therein not misleading (ii) an untrue statement or alleged untrue statement of a material fact contained in the Time of Sale Disclosure Package, any Written Testing-the-Waters Communications, any Prospectus, the Final Prospectus, or any amendment or supplement thereto, any Issuer Free Writing Prospectus, or the Marketing Materials or in any other materials used in connection with the offering of the Shares, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, (iii) in whole or in part, any material inaccuracy in the representations and warranties of the Company contained herein, or (iv) in whole or in part, any material failure of the Company to perform its obligations hereunder or under law, and will reimburse such party for any legal or other expenses reasonably incurred by such party in connection with evaluating, investigating or defending against such loss, claim, damage, liability or action; provided, however, that such indemnity shall not inure to the benefit of the Underwriter (or any person controlling the Underwriter) in any such case to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Time of Sale Disclosure Package, any Written Testing-the-Waters Communications, any Prospectus, the Final Prospectus, or any amendment or supplement thereto or any Issuer Free Writing Prospectus, in reliance upon and in conformity with written information furnished to the Company by the related Underwriter specifically for use in the preparation thereof, which written information is described in Section 8(g).
26
(b) The Selling Shareholder will indemnify, defend and hold harmless the Underwriter against any losses, claims, damages or liabilities, joint or several, to which the Underwriter may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) in whole or in part, any material inaccuracy in the representations and warranties of the Selling Shareholder contained herein, or (iii) in whole or in part, any material failure of the Selling Shareholder to perform its obligations hereunder or under law, and will reimburse the Underwriter for any legal or other expenses reasonably incurred by it in connection with evaluating, investigating or defending against such loss, claim, damage, liability or action; provided, however, that the Selling Shareholder shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus, or any amendment or supplement thereto or any Issuer Free Writing Prospectus, in reliance upon and in conformity with written information furnished to the Company by the Underwriter specifically for use in the preparation thereof, which written information is described in Section 8(g).
(c) The Underwriter will indemnify, defend and hold harmless the Company, its directors and each officer of the Company who signs the Registration Statement and the Selling Shareholder and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any losses, claims, damages or liabilities to which such party may become subject, under the Securities Act or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of the Underwriter), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus, or any amendment or supplement thereto or any Issuer Free Writing Prospectus, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus, or any amendment or supplement thereto or any Issuer Free Writing Prospectus in reliance upon and in conformity with written information furnished to the Company by the Underwriter specifically for use in the preparation thereof, which written information is described in Section 8(g), and will reimburse such party for any legal or other expenses reasonably incurred by such party in connection with evaluating, investigating, and defending against any such loss, claim, damage, liability or action. The obligation of the Underwriter to indemnify the Company or the Selling Shareholder (including any controlling person, director or officer thereof) shall be limited to the amount of the underwriting discount applicable to the Shares to be purchased by the Underwriter hereunder actually received by the Underwriter.
27
(d) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof; but the failure to notify the indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party except to the extent such indemnifying party has been materially prejudiced by such failure. In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of the indemnifying party’s election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof; provided, however, that if (i) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (ii) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party), or (iii) the indemnifying party has not in fact employed counsel reasonably satisfactory to the indemnified party to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, the indemnified party shall have the right to employ a single counsel to represent it in any claim in respect of which indemnity may be sought under subsection (a) or (b) of this Section 10, in which event the reasonable fees and expenses of such separate counsel shall be borne by the indemnifying party or parties and reimbursed to the indemnified party as incurred.
The indemnifying party under this Section 8 shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is a party or could be named and indemnity was or would be sought hereunder by such indemnified party, unless such settlement, compromise or consent (a) includes an unconditional release of such indemnified party from all liability for claims that are the subject matter of such action, suit or proceeding and (b) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
28
(e) If the indemnification provided for in this Section 8 is unavailable or insufficient to hold harmless an indemnified party under subsection (a) or (b) above, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a) or (b) above, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and the Selling Shareholder on the one hand and the Underwriter on the other from the offering and sale of the Shares or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and the Selling Shareholder on the one hand and the Underwriters on the other in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Selling Shareholder on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company and the Selling Shareholder bear to the total underwriting discount received by the Underwriters, in each case as set forth in the table on the cover page of the Final Prospectus. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, the Selling Shareholder or the Underwriter and the parties’ relevant intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company, the Selling Shareholder and the Underwriter agree that it would not be just and equitable if contributions pursuant to this subsection (e) were to be determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the first sentence of this subsection (e). The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection (e) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending against any action or claim that is the subject of this subsection (e). Notwithstanding the provisions of this subsection (e), no Underwriter shall be required to contribute any amount in excess of the amount of the underwriting discount applicable to the Shares to be purchased by the Underwriter hereunder actually received by the Underwriter. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters’ respective obligations to contribute as provided in this Section 8 are several in proportion to their respective underwriting commitments and not joint.
(f) The obligations of the Company and the Selling Shareholder under this Section 8 shall be in addition to any liability that the Company and the Selling Shareholder may otherwise have and the benefits of such obligations shall extend, upon the same terms and conditions, to each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act; and the obligations of the Underwriter under this Section 7 shall be in addition to any liability that the Underwriter may otherwise have and the benefits of such obligations shall extend, upon the same terms and conditions, to the Company, its officers, directors and each person who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and the Selling Shareholder.
(g) For purposes of this Agreement, the Underwriter severally confirms, and the Company and the Selling Shareholder acknowledges, that there is no information concerning the Underwriter furnished in writing to the Company and the Selling Shareholder by the Underwriter specifically for preparation of or inclusion in the Registration Statement, the Time of Sale Disclosure Package, any Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus, other than the statement set forth in the last paragraph on the cover page of the Prospectus, the marketing and legal names of the Underwriter, and the statements set forth in the “Underwriting” section of the Registration Statement, the Time of Sale Disclosure Package, and the Final Prospectus only insofar as such statements relate to the amount of selling concession and re-allowance, if any, or to over-allotment, stabilization and related activities that may be undertaken by the Underwriter.
29
9. Representations and Agreements to Survive Delivery. All representations, warranties, and agreements of the Company and the Selling Shareholder contained herein or in certificates delivered pursuant hereto, including, but not limited to, the agreements of the several Underwriters, the Selling Shareholder and the Company contained in Section 6(a)(viii) and Section 8 hereof, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Underwriter or any controlling person thereof, or the Company, any of its officers, directors, or controlling persons, and the Selling Shareholder, and shall survive delivery of, and payment for, the Shares to and by the Underwriters hereunder.
10. Termination of this Agreement.
(a) The Underwriter shall have the right to terminate this Agreement by giving notice to the Company and the Selling Shareholder as hereinafter specified at any time at or prior to the Closing Date or any Option Closing Date (as to the Option Shares to be purchased on such Option Closing Date only), if in the discretion of the Underwriter, (i) there has occurred any material adverse change in the securities markets or any event, act or occurrence that has materially disrupted, or in the opinion of the Underwriter, will in the future materially disrupt, the securities markets or there shall be such a material adverse change in general financial, political or economic conditions or the effect of international conditions on the financial markets in the United States is such as to make it, in the reasonable judgment of the Underwriter, inadvisable or impracticable to market the Shares or enforce contracts for the sale of the Shares (ii) trading in the Company’s Common Stock shall have been suspended by the Commission or Nasdaq or trading in securities generally on the Nasdaq Stock Market, the NYSE or NYSE MKT shall have been suspended, (iii) minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required, on the Nasdaq Stock Market, the NYSE or NYSE MKT, by such exchange or by order of the Commission or any other governmental authority having jurisdiction, (iv) a banking moratorium shall have been declared by federal or state authorities, (v) there shall have occurred any attack on, outbreak or escalation of hostilities or act of terrorism involving the United States, any declaration by the United States of a national emergency or war, any substantial change or development involving a prospective substantial change in the United States political, financial or economic conditions or any other calamity or crisis, or (vi) the Company suffers any material loss by strike, fire, flood, earthquake, accident or other calamity, whether or not covered by insurance, or (vii) in the reasonable judgment of the Underwriter, there has been, since the time of execution of this Agreement or since the respective dates as of which information is given in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, any material adverse change in the assets, properties, condition, financial or otherwise, or in the results of operations, business affairs or business prospects of the Company and its Subsidiaries considered as a whole, whether or not arising in the ordinary course of business. Any such termination shall be without liability of any party to any other party except that the provisions of Section 6(a)(viii) and Section 8 hereof shall at all times be effective and shall survive such termination.
30
(b) If the Underwriter elects to terminate this Agreement as provided in this Section, the Company and the Selling Shareholder shall be notified promptly by the Underwriter by telephone, confirmed by letter.
11. Notices. Except as otherwise provided herein, all communications hereunder shall be in writing and, if to the Underwriter, shall be mailed, delivered or telecopied to the parties as follows:
if to the Underwriter:
Roth Capital Partners, LLC
800 San Clemente Drive, Suite 400
Newport Beach, CA 92660
E-mail:
Attention: Managing Director
with copies to:
Pryor Cashman LLP
7 Times Square
New York, New York 10036
E-mail:
Attention: M. Ali Panjwani, Esq.
if to the Company:
Fathom Holdings Inc.
211 New Edition Court, Suite 211
Cary, North Carolina 27511
E-mail:
Attention: Chief Executive Officer
with copies to:
Wyrick Robbins Yates & Ponton LLP
4101 Lake Boone Trail, Suite 300
Raleigh, North Carolina 27607
E-mail:
Attention: Donald R. Reynolds, Esq.
if to the Selling Shareholder:
Mr. Glenn Sampson
c/o Fathom Holdings Inc.
211 New Edition Court, Suite 211
Cary, North Carolina 27511
E-mail:
31
or in each case to such other address as the person to be notified may have requested in writing. Any party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.
12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns and the controlling persons, officers and directors referred to in Section 8. Nothing in this Agreement is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy or claim under or in respect of this Agreement or any provision herein contained. The term “successors and assigns” as herein used shall not include any purchaser, as such purchaser, of any of the Shares from the Underwriter.
13. Absence of Fiduciary Relationship. The Company and the Selling Shareholder acknowledge and agree that: (a) the Underwriter has been retained solely to act as underwriter in connection with the sale of the Shares and that no fiduciary, advisory or agency relationship between the Company and the Selling Shareholder and the Underwriter has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Underwriter has advised or is advising the Company or the Selling Shareholder on other matters; (b) the price and other terms of the Shares set forth in this Agreement were established by the Company and the Selling Shareholder following discussions and arms-length negotiations with the Underwriter and the Company and the Selling Shareholder is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement; (c) it has been advised that the Underwriter and its affiliates are engaged in a broad range of transactions that may involve interests that differ from those of the Company and the Selling Shareholder and that no Underwriter has any obligation to disclose such interest and transactions to the Company or the Selling Shareholder by virtue of any fiduciary, advisory or agency relationship; and (d) it has been advised that the Underwriter is acting, in respect of the transactions contemplated by this Agreement, solely for the benefit of the Underwriter, and not on behalf of the Company or the Selling Shareholder.
14. Amendments and Waivers. No supplement, modification or waiver of this Agreement shall be binding unless executed in writing by the party to be bound thereby. The failure of a party to exercise any right or remedy shall not be deemed or constitute a waiver of such right or remedy in the future. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (regardless of whether similar), nor shall any such waiver be deemed or constitute a continuing waiver unless otherwise expressly provided.
15. Partial Unenforceability. The invalidity or unenforceability of any section, paragraph, clause or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph, clause or provision.
16. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.
32
17. Submission to Jurisdiction. The Company and the Selling Shareholder irrevocably (a) submits to the jurisdiction of the Supreme Court of the State of New York, Borough of Manhattan or the United States District Court for the Southern District of New York for the purpose of any suit, action, or other proceeding arising out of this Agreement, or any of the agreements or transactions contemplated by this Agreement, the Registration Statement, the Time of Sale Disclosure Package, any Prospectus and the Final Prospectus (each a “Proceeding”), (b) agrees that all claims in respect of any Proceeding may be heard and determined in any such court, (c) waives, to the fullest extent permitted by law, any immunity from jurisdiction of any such court or from any legal process therein, (d) agrees not to commence any Proceeding other than in such courts, and (e) waives, to the fullest extent permitted by law, any claim that such Proceeding is brought in an inconvenient forum. EACH OF THE COMPANY (ON BEHALF OF ITSELF AND, TO THE FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE EQUITY HOLDERS AND CREDITORS) and the Selling Shareholder HEREBY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, THE REGISTRATION STATEMENT, THE TIME OF SALE DISCLOSURE PACKAGE, ANY PROSPECTUS AND THE FINAL PROSPECTUS.
18. Counterparts. This Agreement may be executed and delivered (including by facsimile transmission or electronic mail) in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument.
[Signature Page Follows]
33
Please sign and return to the Company the enclosed duplicates of this letter whereupon this letter will become a binding agreement between the Company, the Selling Shareholder and the Underwriter in accordance with its terms.
Very truly yours, | ||
FATHOM HOLDINGS INC. | ||
By: | ||
Name: | ||
Title: | ||
GLENN SAMPSON | ||
Selling Shareholder | ||
By: | ||
Glenn Sampson |
Confirmed as of the date first above-mentioned
by the Underwriter.
ROTH CAPITAL PARTNERS, LLC | ||
By: | ||
Name: | Aaron M. Gurewitz | |
Title: | Head of Equity Capital Markets |
[Signature page to Underwriting Agreement]
SCHEDULE I
Name | Number of Firm Shares to be Purchased | Number of Company Option Shares to be Purchased | Number of Secondary Shares to be Purchased | |||
Roth Capital Partners, LLC | [ ] | [ ] | [ ] |
SCHEDULE II
Number of Firm Shares to be Sold | Number of Company Option Shares and Secondary Shares to be Sold | |||||
Company: | [ ] | [ ] | ||||
Glenn Sampson, selling shareholder: | 0 | [ ] | ||||
Total | [ ] | [ ] |
SCHEDULE III
Final Term Sheet
Issuer: | Fathom Holdings Inc. (the “Company”) | |
Symbol: | ||
Securities: | [●] shares of common stock, no par value per share (the “Common Stock”), of the Company | |
Over-allotment option: | Up to an additional [●] shares of Common Stock at a price of $[●] per share | |
Public offering price: | $[●] per share of Common Stock | |
Underwriting discount: | $[●] per share of Common Stock | |
Expected net proceeds: | Approximately $[●] million ($[●] if the overallotment option is exercised in full) (after deducting the underwriting discount and estimated offering expenses payable by the Company). | |
Trade date: | ,2020 | |
Settlement date: | ,2020 | |
Underwriter: |
Roth Capital Partners, LLC |
SCHEDULE IV
Free Writing Prospectus
SCHEDULE V
Written Testing-the-Waters Communications
SCHEDULE VI
List of officers, directors and shareholders executing lock-up agreements
EXHIBIT A
Form of Lock-Up Agreement
Roth Capital Partners, LLC
888 San Clemente Drive
Newport Beach, CA 92660
Ladies and Gentlemen:
The undersigned understands that you, as the representative (the “Representative”) of the several underwriters named therein, propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Fathom Holdings Inc., a North Carolina corporation (the “Company”), relating to a proposed offering of securities of the Company (the “Offering”) including shares of the Common Stock, no par value (the “Common Stock”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
In consideration of the foregoing, and in order to induce you to participate the Offering, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Representative (which consent may be withheld in its sole discretion), the undersigned will not, during the period (the “Lock-Up Period”) beginning on the date hereof and ending on the date 180 days after the date of the final prospectus relating to the Offering (the “Final Prospectus”), (1) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or file (or participate in the filing of) a registration statement with the Securities and Exchange Commission in respect of, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock (including without limitation, shares of Common Stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant), (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the shares of, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of shares of Common Stock or such other securities, in cash or otherwise, (3) make any demand for or exercise any right with respect to, the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for shares of Common Stock, or (4) publicly announce an intention to effect any transaction specific in clause (1), (2) or (3) above.
Notwithstanding the foregoing, the restrictions set forth in clause (1) and (2) above shall not apply to (a) transfers (i) as a bona fide gift or gifts, provided that the donee or donees thereof agree to be bound in writing by the restrictions set forth herein, or (ii) to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned, provided that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further that any such transfer shall not involve a disposition for value, (b) the acquisition or exercise of any stock option issued pursuant to the Company’s existing stock option plan, including any exercise effected by the delivery of shares of Common Stock of the Company held by the undersigned, or (c) the establishment of a plan for the sale of the Company’s securities that satisfies all of the requirements of Rule 10b5-1(c)(1)(i)(B), so long as no sales may occur thereunder during the Lock-Up Period. For purposes of this Lock-Up Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.
The foregoing restrictions are expressly agreed to preclude the undersigned from engaging in any hedging or other transaction which is designed to or reasonably expected to lead to or result in a sale or disposition of shares of Common Stock even if such securities would be disposed of by someone other than the undersigned. Such prohibited hedging or other transactions would include without limitation any short sale or any purchase, sale or grant of any right (including without limitation any put option or put equivalent position or call option or call equivalent position) with respect to any of the shares of Common Stock or with respect to any security that includes, relates to, or derives any significant part of its value from such shares.
The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned.
The undersigned also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar or depositary against the transfer of the undersigned’s shares of Common Stock except in compliance with the foregoing restrictions.
If the undersigned is an officer or director of the Company, (i) the Representative agrees that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of Common Shares, the Representative will notify the Company of the impending release or waiver, and (ii) the Company will agree in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at least two business days before the effective date of the release or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described in this letter to the extent and for the duration that such terms remain in effect at the time of the transfer.
The undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the securities to be sold thereunder, the undersigned shall be released from all obligations under this Lock-Up Agreement.
This Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. The undersigned irrevocably (i) submits to the jurisdiction of the Supreme Court of the State of New York, Borough of Manhattan and the United States District Court for the Southern District of New York, for the purpose of any suit, action, or other proceeding arising out of this Lock-Up Agreement (each a “Proceeding”), (ii) agrees that all claims in respect of any Proceeding may be heard and determined in any such court, (iii) waives, to the fullest extent permitted by law, any immunity from jurisdiction of any such court or from any legal process therein, (iv) agrees not to commence any Proceeding other than in such courts, and (v) waives, to the fullest extent permitted by law, any claim that such Proceeding is brought in an inconvenient forum.
Very truly yours, | |
Name: |
EXHIBIT B
Form of Press Release
Fathom Holdings Inc.
[Date]
Fathom Holdings Inc., a North Carolina corporation (the “Company”) announced today that Roth Capital Partners, LLC the [Representative] in the Company’s recent public sale of shares of common stock are [waiving][releasing] a lock-up restriction with respect to shares of the Company’s common stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on , 20 , and the shares may be sold on or after such date.
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
EXHIBIT C
Company Counsel Opinion
EXHIBIT D
Selling Shareholder Opinion
Exhibit 3.1.1
FORM OF
ARTICLES OF AMENDMENT
OF
FATHOM HOLDINGS INC.
Pursuant to Section 55-10-06 of the North Carolina General Statutes, the undersigned corporation hereby submits the following Articles of Amendment for the purpose of amending its Restated Articles of Incorporation.
1. | The name of the corporation is Fathom Holdings Inc. |
2. | The Restated Articles of Incorporation are hereby amended as follows: |
Article IV is hereby amended by adding the following paragraph:
“Effective at ____ p.m. on July ___, 2020 (the “Effective Time”), every currently outstanding 4.71352 shares of Common Stock of the Corporation as of immediately prior to the Effective Time shall automatically be reclassified and combined into 1 share of Common Stock of the Corporation, each with no par value per share (the “Reverse Stock Split”). No fractional interest resulting from the Reverse Stock Split shall be issued, and if such fractional share results, the number of shares to be issued to any such shareholder in connection with the Reverse Stock Split will be rounded up to the nearest share. All numbers of shares, and all amounts stated on a per share basis contained in these restated articles of incorporation are stated after giving effect to such Reverse Stock Split and no further adjustment shall be made as a consequence of such Reverse Stock Split.”
3. | The amendment set forth herein was duly adopted by the corporation’s shareholders on July ___, 2020, in the manner required by Chapter 55 of the North Carolina General Statutes. |
4. | These Articles of Amendment will become effective at ____ p.m. Eastern Daylight Time on July ___, 2020. |
This the ____ day of July, 2020.
By: | ||
Joshua Harley, President |
Exhibit 3.2
SECOND
AMENDED & RESTATED
BYLAWS
OF
FATHOM HOLDINGS INC.
ARTICLE I
OFFICES
1.1 | Principal Office. The principal office of the corporation shall be located at such place as the Board of Directors may fix from time to time. |
1.2 | Registered Office. The registered office of the corporation required by law to be maintained in the State of North Carolina may be, but need not be, identical with the principal office. |
1.3 | Other Offices. The corporation may have offices at such other places, either within or without the State of North Carolina, as the Board of Directors may designate or as the affairs of the corporation may require from time to time. |
ARTICLE II
MEETINGS OF SHAREHOLDERS
2.1 | Place of Meetings. All meetings of shareholders shall be held at the principal office of the corporation, or at such other place, whether within or without the State of North Carolina, as shall be designated in the notice of the meeting or agreed upon by the Board of Directors. |
2.2 | Annual Meeting. The annual meeting of shareholders shall be held at such place and on such date as established by the Board of Directors (except a Saturday, Sunday or a legal holiday) and at such time as is determined by the Board of Directors, for the purpose of electing directors of the corporation and for the transaction of such other business as may be properly brought before the meeting. |
2.3 | Substitute Annual Meetings. If the annual meeting shall not be held on the day designated by these Bylaws, a substitute annual meeting may be called in accordance with the provisions of Section 2.4 of this Article II. A meeting so called shall be designated and treated for all purposes as the annual meeting. |
2.4 | Special Meetings. Special meetings of the shareholders may be called at any time by the Board of Directors, Chairman of the Board or President of the corporation, or by any shareholder pursuant to the written request of the holders of a majority of all shares entitled to vote at the meeting. |
2.5 | Notice of Meetings. |
(a) Written or printed notice stating the time and place of any meeting of the shareholders shall be delivered not less than ten (10) nor more than sixty (60) days before the date of any shareholders' meeting, either personally, by United States mail, nationally recognized courier or delivery service or, if in electronic form, by electronic mail or other electronic means by or at the direction of the Board of Directors, Chairman of the Board or President or other person calling the meeting, to each shareholder of record entitled to vote at such meeting; provided that such notice must be given to all shareholders with respect to any meeting at which a merger, share exchange, sale of assets other than in the regular course of business or voluntary dissolution is to be considered and in such other instances as required by law. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at his address as it appears on the record of shareholders of the corporation, with postage thereon prepaid.
(b) In the case of a special meeting, the notice of meeting shall specifically state the purpose or purposes for which the meeting is called; but, in the case of an annual or substitute annual meeting, the notice of meeting need not specifically state the business to be transacted thereat unless such a statement is required by the provisions of the North Carolina Business Corporation Act.
(c) When a meeting is adjourned to a different date, time or place, notice need not be given of the new date, time or place if the new date, time or place is announced at the meeting before adjournment. If, however, a new record date for the adjourned meeting is fixed, notice of the adjourned meeting will be given to all persons who are shareholders as of the new record date in accordance with this Section 2.5.
(d) To the extent that a shareholder has agreed in writing and delivered such agreement to the corporation, any notice delivered pursuant hereto by electronic mail or other electronic means is effective when sent as provided in the North Carolina Business Corporation Act. Any shareholder may terminate such agreement at any time by written notice to the corporation and such notice of termination shall be effective upon receipt by the corporation. The corporation shall maintain with its corporate records an accounting of all such shareholders agreements and such notices of termination received by the corporation pursuant to the foregoing.
2.6 | Waiver of Notice. Any shareholder may waive notice of any meeting. The waiver must be in writing, signed by the shareholder and delivered to the corporation for inclusion in the minutes or filing with the corporate records. A shareholder's attendance at a meeting (a) waives objection to lack of notice or defective notice of the meeting, unless the shareholder at the beginning of the meeting objects to holding the meeting or transacting business at the meeting; and (b) waives objection to consideration of a particular matter at the meeting that is not within the purpose or purposes described in the meeting notice, unless the shareholder objects to considering the matter before it is voted upon. | |
2.7 | Notice of Shareholder Proposals and Nominees for Election as Directors. |
(a) No business shall be transacted at a meeting of shareholders, except such business as shall be (i) specified in the notice of meeting given as provided in Section 2.5 of this Article, (ii) presented by or at the direction of the board of directors, or (iii) otherwise brought before the meeting by a shareholder of record entitled to vote at the meeting in compliance with the procedures set forth in this Section 2.7. In addition to the requirements of any applicable law with respect to any proposal presented by a shareholder for action at a meeting of the shareholders of the corporation (including the requirements of the Securities and Exchange Commission relating to shareholder proposals and director nominees), and subject to the provisions of the North Carolina Business Corporation Act as in effect from time to time, any shareholder desiring to introduce any business before any meeting of the shareholders of the corporation shall be required to deliver to the secretary written notice containing the information specified herein (i) in the case of an annual meeting, at least 80 days but no more than 120 days in advance of the first anniversary of the notice date of the corporation’s proxy statement for the preceding year’s annual meeting, and (ii) in the case of a special meeting, no later than the tenth day following the notice date for such meeting. In the event that the date of an annual meeting is advanced by more than 30 days or delayed by more than 60 days from the first anniversary date of the preceding year’s annual meeting, notice by a shareholder must be delivered no earlier than the 120th day prior to such annual meeting and no later than the later of the 80th day prior to such annual meeting or the tenth day following the notice date for such meeting. The written notice required herein shall, as to each matter the shareholder proposes to bring before the meeting, contain the following information (in addition to any information required by applicable law): (i) the name and address of the shareholder who intends to present the proposal and the beneficial owner, if any, on whose behalf the proposal is made; (ii) the number of shares of each class of capital stock beneficially owned by the shareholder and such beneficial owner; (iii) a description of the business proposed to be introduced to the shareholders; (iv) any material interest, direct or indirect, which the shareholder or beneficial owner may have in the business described in the notice; and (v) a representation that the shareholder is a holder of record of shares of the corporation entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to present the proposal.
2
(b) Only persons who are nominated in accordance with the provisions set forth in these bylaws and who otherwise comply with director qualification standards established by the board of directors, a properly authorized committee of the board, or applicable law, rule or regulation shall be eligible to be elected as directors at a meeting of shareholders. Nominations of persons for election to the board of directors may be made at such meeting of shareholders only (i) by or at the direction of the board of directors (or a properly authorized committee of the board) or (ii) by any shareholder (A) who is a shareholder of record at the time of giving of notice provided for in this Section 2.7, (B) who is entitled to vote for the election of directors at the meeting, (C) who complies with the notice and other procedures set forth in this Section 2.7 and (D) whose nominee is determined by the board of directors (or a properly authorized committee of the board) to satisfy all applicable director qualification standards. Any shareholder desiring to nominate a person for election as a director of the corporation shall deliver to the Secretary a written notice at such time and containing (i) such information as set forth in this Section 2.7, (ii) such additional information concerning the nominee as would be required, pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (or any successor provision thereto), to be disclosed in the proxy materials concerning all persons nominated (by the corporation or otherwise) for election as a director of the corporation, and (iii) such additional information concerning the nominee as is deemed sufficient by the board of directors (or a properly authorized committee of the board) to establish that the nominee meets all minimum qualification standards or other criteria as may have been established by the board of directors (or any properly authorized committee of the board) or pursuant to applicable law, rule or regulation for service as a director. In addition, such notice shall be accompanied by a consent signed by each nominee to serve as a director if elected.
(c) Failure of any shareholder to provide such notice in a timely and proper manner as set forth in this Section 2.7 shall authorize the presiding officer at the meeting of shareholders before which such business is proposed to be introduced, or at which such nominee is proposed to be considered for election as a director, to rule such proposal or nomination out of order and not proper to be introduced or considered.
2.8 | Shareholder Lists. Before each meeting of shareholders, the Secretary of the corporation shall prepare an alphabetical list of the shareholders entitled to notice of such meeting. The list shall be arranged by voting group (and within each voting group by class or series of shares) and show the address and number of shares held by each shareholder. The list shall be kept on file at the principal office of the corporation, or at a place identified in the meeting notice in the city where the meeting will be held, for the period beginning two business days after notice of the meeting is given and continuing through the meeting, and shall be subject to inspection by any shareholder at any time during regular business hours. This list shall also be produced and kept open at the time and place of the meeting and shall be subject to inspection by any shareholder during the meeting or any adjournment thereof. |
2.9 | Quorum. |
(a) A majority of the outstanding shares of the corporation entitled to vote and represented in person or by proxy shall be required for, and shall constitute a quorum at all meetings of shareholders. Shares entitled to vote as a separate voting group may take action on a matter only if a quorum of those shares exists; a majority of the votes entitled to be cast on the matter by the voting group constitutes a quorum of that voting group. The shareholders present at a duly organized meeting may continue to do business until adjournment, notwithstanding the withdrawal of enough shareholders to leave less than a quorum.
(b) In the absence of a quorum at the opening of any meeting of shareholders, such meeting may be adjourned from time to time by a vote of a majority of the shares voting on the motion to adjourn; and at any adjourned meeting at which a quorum is present, any business may be transacted that might have been transacted at the original meeting.
3
2.10 | Organization. Each meeting of shareholders shall be presided over by the Chairman of the Board, and in his absence or at his request by the President, and in their absence or at their request by any person selected to preside by vote of the holders of a majority of the shares present and entitled to vote at the meeting. The Secretary, or in his absence or at his request, any person designated by the person presiding at the meeting, shall act as secretary of the meeting. |
2.11 | Proxies. Shares may be voted either in person or by one or more agents authorized by a written proxy executed by the shareholder or by his duly authorized attorney-in-fact. A proxy is not valid after the expiration of eleven months from the date of its execution, unless the person executing it specifies therein the length of time for which it is to continue in force, or limits its use to a particular meeting. Any proxy shall be revocable by the shareholder unless the written appointment expressly and conspicuously provides that it is irrevocable and the appointment is coupled with an interest as required by law. |
2.12 | Voting of Shares. |
(a) Subject to the provisions of Section 3.1 of the corporation's Articles of Incorporation and Section 3.3 of these bylaws, each outstanding share entitled to vote shall be entitled to one vote on each matter submitted to a vote at a meeting of shareholders. All shares entitled to vote shall be counted together collectively on a matter as provided by the Articles of Incorporation or by the North Carolina Business Corporation Act shall constitute a single voting group. Additional required voting groups shall be determined in accordance with the Articles of Incorporation and these Bylaws of this corporation and the North Carolina Business Corporation Act.
(b) Except in the election of directors as governed by the provisions of Section 3.3 of Article III of these bylaws, the vote of a majority of the shares voted on any matter at a meeting of shareholders at which a quorum is present shall be the act of the shareholders on that matter, unless the vote of a greater number is required by law or by the Articles of Incorporation or Bylaws of this corporation. Further, except in the election of directors, action on a matter by a voting group shall be approved if the votes cast within the voting group favoring the action exceed the votes cast opposing the action, unless the vote by a greater number is required by law or by the Articles of Incorporation or Bylaws of this corporation. Corporate action on such matters shall be taken only when approved by each and every voting group entitled to vote as a separate voting group on such matters as provided by the Articles of Incorporation or Bylaws of this corporation or by the North Carolina Business Corporation Act.
(c) Voting on all matters except the election of directors shall be by voice vote or by a show of hands unless the holders of one-tenth (1/10th) of the shares represented at the meeting shall, prior to the voting on any matter, demand a ballot vote on that particular matter. Abstentions shall not be treated as negative votes.
(d) Shares of the corporation's stock are not entitled to vote if they are owned, directly or indirectly, by a second corporation and the corporation owns, directly or indirectly, a majority of the shares entitled to vote for directors of the second corporation, except that shares held in a fiduciary capacity, including the corporation's own shares, may be voted.
4
2.13 | Informal Action By Shareholders. |
(a) Unless otherwise provided in the corporation’s Articles of Incorporation, any action required or permitted to be taken at a meeting of the shareholders may be taken without a meeting and without prior notice, if a consent in writing, setting forth the action so taken, shall be delivered to the corporation for inclusion in the corporate records and shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take the action at a meeting at which all shareholders entitled to vote thereon were present and voted. Such consent shall have the same force and effect as a vote of the shareholders. A shareholder’s consent to action taken without meeting may be in electronic form and may be delivered to the corporation in the manner herein required.
(b) Every written consent shall bear the date of signature of such consent, and no written consent shall be effective to take the corporate action referred to therein unless, within sixty (60) days of the earliest consent delivered to the corporation in the manner herein required, written consents signed by a sufficient number of shareholders to take such action are delivered to the corporation by delivery to its registered office in the State of North Carolina, its principal place of business or an officer or agent of the corporation having custody of the records in which proceedings of meetings of the shareholders are recorded. Delivery to the corporation of shareholders’ written consents shall be by hand, certified or registered mail, return receipt requested, regular mail, nationally recognized courier or delivery service or, if in electronic form, by electronic mail or other electronic means to such address or other location as may from time to time be determined by the Board of Directors.
(c) If action is taken without a meeting by fewer than all shareholders entitled to vote on the action, the corporation shall give written notice to all shareholders who have not consented to the action and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting with the same record date as the action taken without a meeting, within ten (10) days after the action is taken. The notice shall describe the action and indicate that the action has been taken without a meeting of shareholders.
2.14 | Inspectors of Election. |
(a) Appointment of Inspectors of Election. In advance of any meeting of shareholders, the Board of Directors may appoint any persons, other than nominees for office, as inspectors of election to act at such meeting or any adjournment thereof. If inspectors of election are not so appointed, the chairman of any such meeting may appoint inspectors of election at the meeting. The number of inspectors shall be either one or three. In case any person appointed as inspector fails to appear or fails or refuses to act, the vacancy may be filled by appointment by the Board of Directors in advance of the meeting or at the meeting by the person acting as chairman.
(b) Duties of Inspectors. The inspectors of election shall determine the number of shares outstanding and the voting power of each, the shares represented at the meeting, the existence of a quorum, the authenticity, validity and effect of proxies, receive votes, ballots or consents, hear and determine all challenges and questions in any way arising in connection with the right to vote, count and tabulate all votes or consents, determine the result and do such acts as may be proper to conduct the election or vote with fairness to all shareholders. The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical.
(c) Vote of Inspectors. If there are three inspectors of election, the decision, act or certificate of a majority shall be effective in all respects as the decision, act or certificate of all.
(d) Report of Inspectors. On a request of the chairman of the meeting, the inspectors shall make a report in writing of any challenge or question or matter determined by them and shall execute a certificate of any fact found by them. Any report or certificate made by them shall be a prima facie evidence of the facts stated therein.
5
2.15 | Electronic Participation in Meetings. Any shareholder or any shareholder’s proxy may participate in any meeting of the shareholders by means of a conference telephone or similar communications device that allows all persons participating in the meeting (a) to read or to hear the meeting proceeding substantially concurrently as the proceedings occur, (b) to be read or to be heard substantially concurrently as the proceedings occur, and (c) to vote on matters to which the shareholder or shareholder’s proxy is entitled to vote, and such participation in a meeting shall be deemed presence in person at such meeting. |
ARTICLE III
BOARD OF DIRECTORS
3.1 | General Powers. All corporate powers shall be exercised by or under the authority of, and the business and affairs of the corporation managed under the direction of, its Board of Directors or by such executive or other committees as the Board may establish pursuant to these Bylaws. |
3.2 | Number and Qualifications. The number of directors constituting the Board of Directors shall range from one (1) to nine (9); initially set at five (5). The number of directors may be fixed or changed from time to time within the minimum and maximum by the Board of Directors or the shareholders. Directors need not be residents of the State of North Carolina or shareholders of the corporation. |
3.3 | Election of Directors. Except as provided in Section 3.6 of this Article III, the directors shall be elected at the annual meeting of shareholders; and those persons who receive the highest number of votes shall be deemed to have been elected. Every shareholder entitled to vote at an election of directors shall have the right to vote the number of shares standing of record in his name for as many persons as there are directors to be elected and for whose election he has a right to vote, or, if cumulative voting rights have been provided for in the corporation's Articles of Incorporation, to cumulate his vote by giving one candidate as many votes as the number of such directors multiplied by the number of his shares shall equal, or by distributing such votes on the same principle among any number of such candidates. This right of cumulative voting, if available to the shareholders, shall not be exercised unless (a) the meeting notice or proxy statement accompanying the notice states conspicuously that shareholders are entitled to cumulate their votes, or (b) a shareholder or proxy holder who has the right to cumulate his votes announces in open meeting, before the voting for the directors starts, his intention so to vote cumulatively; and if such announcement is made, the chair shall declare that all shares entitled to vote have the right to vote cumulatively and shall announce the number of shares present in person and by proxy and shall thereupon grant a recess of not less than one nor more than four hours, as he shall determine, or of such other period of time as is unanimously then agreed upon. |
3.4 | Term of Directors. Each initial director shall hold office until the first shareholders' meeting at which directors are elected, or until such director's death, resignation or removal. The terms of every other director shall expire at the next annual shareholders' meeting following a director's election or upon such director's death, resignation or removal. The term of a director elected to fill a vacancy expires at the next shareholders' meeting at which directors are elected. Despite the expiration of a director's term, such director shall continue to serve until a qualified successor shall be elected. A decrease in the number of directors does not shorten an incumbent director's term. |
3.5 | Removal. Any director may be removed at any time with or without cause by a vote of the shareholders if the number or votes cast to remove such director exceeds the number of votes cast not to remove him. However, if cumulative voting is authorized, a director shall not be removed when the number of shares voting against the proposal for removal would be sufficient to elect a director if such shares were voted cumulatively at an annual election. If a director is elected by a voting group of shareholders, only the shareholders of that voting group may participate in the vote to remove him. If any directors are so removed, new directors may be elected at the same meeting. A director may not be removed by the shareholders at a meeting unless the notice of the meeting states that the purpose, or one of the purposes, of the meeting, is removal of the director. |
6
3.6 | Vacancies. Any vacancy occurring in the Board of Directors, including, without limitation, a vacancy resulting from an increase in the number of directors or from the failure by the shareholders to elect the full authorized number of directors, may be filled by the shareholders entitled to vote or the Board of Directors, whichever group shall act first. If the directors remaining in office do not constitute a quorum of the Board, the directors may fill the vacancy by the affirmative vote of a majority of the remaining directors. |
3.7 | Chairman of the Board. There may be a Chairman of the Board of Directors elected by the directors from their number at any meeting of the Board. The Chairman shall preside at all meetings of the Board of Directors and perform such other duties as may be directed by the Board. He shall be an ex officio member of all committees. He shall make a report in writing at the annual meeting of the Board of Directors stating the condition of the corporation and shall make such suggestions and recommendations as he shall deem proper for the best interests of the corporation. He shall appoint delegates and representatives to the organizations with which the corporation is affiliated. He shall have the power to call the regular and any special meetings of the Board of Directors. Until a Chairman is elected, the President of the corporation shall preside at the meetings of the Board of Directors and shareholders. |
3.8 | Compensation. The Board of Directors, in its discretion, may compensate directors for their services as such and may provide for the payment of all expenses incurred by directors in attending regular and special meetings of the Board or of the Executive Committee. Nothing herein contained, however, shall be construed to preclude any director from serving the corporation in any other capacity and receiving compensation therefor. |
3.9 | Executive Committees. The Board of Directors, by resolution adopted by a majority of the number of directors in office when the action is taken or, if greater, the number of directors required to take action pursuant to Section 4.6 of Article IV, may designate one or more directors to constitute an Executive Committee and other committees, each of which, to the extent authorized by law and provided in such resolution, shall have and may exercise all of the authority of the Board of Directors in the management of the corporation. Each committee member serves at the pleasure of the Board of Directors. The provisions in these Bylaws that govern meetings, action without meetings, notice and waiver of notice, and quorum and voting requirements of the Board of Directors apply to committees established by the Board. |
ARTICLE IV
MEETINGS OF DIRECTORS
4.1 | Regular Meetings. A regular meeting of the Board of Directors shall be held immediately after, and at the same place as, the annual meeting of the shareholders. In addition, the Board of Directors may provide, by resolution, the time and place, either within or without the State of North Carolina, for the holding of additional regular meetings. |
4.2 | Special Meetings. Special meetings of the Board of Directors may be called by or at the request of the Chairman of the Board of Directors, if any, by the President or any two directors. Such meetings may be held either within or without the State of North Carolina, as fixed by the person or persons calling the meeting. |
4.3 | Notice of Meetings. Regular meetings of the Board of Directors may be held without notice. The person or persons calling a special meeting of the Board of Directors shall, at least 2 days before the meeting, give notice thereof by any usual means of communication including, but not limiting to facsimile, telephone, electronic mail or other form of electronic communication. Such notice need not specify the purpose for which the meeting is called. |
7
4.4 | Waiver of Notice. Any director may waive notice of any meeting. The waiver must be in writing, signed by the director entitled to the notice and delivered to the corporation for inclusion in the minutes or filing with the corporate records. A director's attendance at or participation in a meeting shall constitute a waiver of notice of such meeting, unless the director at the beginning of the meeting (or promptly on arrival) objects to holding the meeting or transacting business at the meeting and does not thereafter vote for or assent to action taken at the meeting. |
4.5 | Quorum. A majority of the directors fixed by these Bylaws or, if the number of directors fixed by these Bylaws has been changed by the Board of Directors or the Shareholders pursuant to Section 3.2 hereof, a majority of the number of directors in office immediately before the meeting begins, shall be required for, and shall constitute, a quorum for the transaction of business at any meeting of the Board of Directors unless the Articles of Incorporation or these Bylaws provide otherwise. |
4.6 | Manner of Acting. Except as otherwise provided in the Articles of Incorporation or these Bylaws, the act of the majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. |
4.7 | Presumption of Assent. A director of the corporation who is present at a meeting of the Board of Directors or a committee of the Board of Directors when corporate action is taken is deemed to have assented to the action taken unless (a) he objects at the beginning of the meeting (or promptly upon his arrival) to holding it or transacting business at the meeting, or (b) his dissent or abstention from the action taken is entered in the minutes of the meeting, or (c) he files written notice of his dissent or abstention with the presiding officer of the meeting before its adjournment or with the corporation immediately after the adjournment. Such right to dissent shall not apply to a director who voted in favor of such action. |
4.8 | Action Without Meeting. Action required or permitted to be taken at a meeting of the Board of Directors may be taken without a meeting if all members of the Board approve the action. The action must be evidenced by one or more written consents signed by each director before or after such action, describing the action taken, and included in the minutes or filed with the corporate records. The consent of any director pursuant hereto may be in writing or in electronic form and may be delivered to the corporation by hand, certified or registered mail, return receipt requested, regular mail, nationally recognized courier or delivery service or, if in electronic form, by electronic mail or other electronic means. Such action will become effective when the last director signs the consent, unless the consent specifies a different date. |
4.9 | Electronic Participation in Meetings. Any one or more directors or members of a committee may participate in a meeting of the Board of Directors or committee by means of a conference telephone or similar communications device that allows all persons participating in the meeting to hear each other, and such participation in a meeting shall be deemed presence in person at such meeting. |
8
ARTICLE V
OFFICERS
5.1 | Officers of the Corporation. The officers of the corporation shall consist of a President, a Secretary, a Treasurer and such Vice-Presidents, Assistant Secretaries, Assistant Treasurers and other officers (including Controllers and Assistant Controllers) as the Board of Directors may from time to time elect. Any two or more offices may be held by the same person, but no officer may act in more than one capacity where action of two or more officers is required. |
5.2 | Appointment and Term. The officers of the corporation shall be appointed by the Board of Directors and each officer shall hold office until his death, resignation, retirement, removal, disqualification, or his successor shall have been appointed and qualified. |
5.3 | Removal. Any officer or agent elected or appointed by the Board of Directors may be removed by the Board at any time with or without cause; but such removal shall be without prejudice to the contract rights, if any, of the person so removed. |
5.4 | Resignation. An officer may resign at any time by communicating his resignation to the corporation, orally or in writing. A resignation is effective when communicated unless it specifies in writing a later effective date. If a resignation is made effective at a later date that is accepted by the corporation, the Board of Directors may fill the pending vacancy before the effective date if the Board provides that the successor does not take office until the effective date. An officer's resignation does not affect the corporation's contract rights, if any, with the officer. |
5.5 | Compensation of Officers. The compensation of all officers of the corporation shall be fixed by the Board of Directors and no officer shall serve the corporation in any other capacity and receive compensation therefor unless such additional compensation be authorized by the Board of Directors. |
5.6 | Chairman of the Board. Unless otherwise specified by resolution of the Board, the Chairman of the Board shall be the Chief Executive Officer of the corporation (and may be identified as such in his title) and, subject to the direction and control of the Board of Directors, shall supervise and control the management of the corporation. The Chairman of the Board shall, when present, preside at all meetings of the directors and shareholders and, in general, shall perform all duties incident to the office of Chairman of the Board and such other duties as may be prescribed from time to time by the Board of Directors. |
5.7 | President. Unless otherwise specified by resolution of the Board, the President, subject to the control of the Board of Directors, shall in general supervise and control all of the business and affairs of the corporation. He shall, in the absence of the Chairman of the Board, preside at all meetings of the shareholders. He shall sign, with the Secretary, an Assistant Secretary, or any other proper officer of the corporation thereunto authorized by the Board of Directors, certificates for shares of the corporation, any deeds, mortgages, bonds, contracts, or other instruments that the Board of Directors has authorized to be executed, except in cases where the signing and execution thereof shall be expressly delegated by the Board of Directors or by these Bylaws to some other officer or agent of the corporation, or shall be required by law to be, otherwise signed or executed; and, in general, he shall perform all duties incident to the office of President and such other duties as may be prescribed by the Board of Directors from time to time. |
12
5.8 | Vice Presidents. In the absence of the President or in the event of his death, inability or refusal to act, the Vice Presidents in the order of their length of service as such, unless otherwise determined by the Board of Directors, shall perform the duties of the President, and when so acting shall have all the powers of and be subject to all the restrictions upon the President. Any Vice President may sign, with the Secretary or an Assistant Secretary, certificates of shares of the corporation; and shall perform such other duties as from time to time may be assigned to him by the President or Board of Directors. The Board of Directors may designate one or more Vice Presidents to be responsible for certain functions, including, without limitation, Marketing, Finance, Manufacturing and Personnel. |
5.9 | Secretary. The Secretary shall: (a) keep the minutes of the meetings of shareholders, of the Board of Directors and of all Executive Committees in one or more books provided for that purpose; (b) see that all notices are duly given in accordance with the provisions of these Bylaws or as required by law; (c) be custodian of the corporate records and of the seal of the corporation and see that the seal of the corporation is affixed to all documents the execution of which on behalf of the corporation under its seal is duly authorized; (d) keep a register of the post office address of each shareholder which shall be furnished to the Secretary by such shareholder; (e) sign with the President, or a Vice President, certificates for shares of the corporation, the issuance of which shall have been authorized by resolution of the Board of Directors; (f) maintain and have general charge of the stock transfer books of the corporation; (g) prepare or cause to be prepared shareholder lists prior to each meeting of shareholders as required by law; (h) attest the signature or certify the incumbency or signature of any officer of the corporation; and (i) in general perform all duties incident to the office of Secretary and such other duties as from time to time may be assigned to him by the President or by the Board of Directors. |
5.10 | Assistant Secretaries. In the absence of the Secretary or in the event of his death, inability or refusal to act, the Assistant Secretaries in the order of their lengths of service as Assistant Secretaries, unless otherwise determined by the Board of Directors, shall perform the duties of the Secretary, and when so acting shall have all the powers of and be subject to all the restrictions upon the Secretary. They shall perform such other duties as may be assigned to them by the Secretary, by the President, or by the Board of Directors. Any Assistant Secretary may sign, with the President or a Vice President, certificates for shares of the corporation. |
5.11 | Treasurer. Unless otherwise designated by the Board of Directors, the Treasurer shall be the Chief Financial Officer (and may be designated as such in his title) and, subject to the discretion of the Board of Directors, shall: (a) have charge and custody of and be responsible for all funds and securities of the corporation; receive and give receipts for monies due and payable to the corporation from any source whatsoever, and deposit all such monies in the name of the corporation in such depositories as shall be selected in accordance with the provisions of Section 6.4 of Article VI of these Bylaws; (b) maintain appropriate accounting records as required by law; (c) prepare, or cause to be prepared, annual financial statements of the corporation that include a balance sheet as of the end of the fiscal year and an income and cash flow statement for that year, which statements, or a written notice of their availability, shall be mailed to each shareholder within one hundred twenty (120) days after the end of such fiscal year; and (d) in general perform all of the duties incident to the office of Treasurer and such other duties as from time to time may be assigned to him by the President or by the Board of Directors, or by these Bylaws. |
13
5.12 | Assistant Treasurers. In the absence of the Treasurer or in the event of his death, inability or refusal to act, the Assistant Treasurers in the order of their length of service as such, unless otherwise determined by the Board of Directors, shall perform the duties of the Treasurer, and when so acting shall have all the powers of and be subject to all the restrictions upon the Treasurer. They shall perform such other duties as may be assigned to them by the Treasurer, by the President or by the Board of Directors. |
5.13 | Controller and Assistant Controllers. The Controller, if one has been appointed, shall have charge of the accounting affairs of the corporation and shall have such other powers and perform such other duties as the Board of Directors shall designate. Each Assistant Controller shall have such powers and perform such duties as may be assigned by the Board of Directors and the Assistant Controller shall exercise the powers of the Controller during that officer's absence or inability to act. |
5.14 | Delegation of Duties of Officers. In case of the absence of any officer of the corporation or for any other reason that the Board may deem sufficient, the Board may delegate the powers or duties of such officer to any other officer or to any director for the time being provided a majority of the entire Board of Directors concurs therein. |
5.15 | Bonds. The Board of Directors may by resolution, require any or all officers, agents or employees of the corporation to give bond to the corporation, with sufficient sureties, conditioned on the faithful performance of the duties of their respective offices or positions, and to comply with such other conditions as may from time to time be required by the Board of Directors. |
ARTICLE VI
CONTRACTS, LOANS, CHECKS AND DEPOSITS
6.1 | Contracts. The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and deliver any instrument in the name of and on behalf of the corporation, and such authority may be general or confined to specific instances. Any resolution of the Board of Directors authorizing the execution of documents by the proper officers of the corporation or by the officers generally shall be deemed to authorize such execution by the Chairman of the Board, the President, any Vice President, or the Treasurer, or any other officer if such execution is generally within the scope of the duties of his office. The Board of Directors may by resolution authorize such execution by means of one or more facsimile signatures. |
6.2 | Loans. No loans shall be contracted on behalf of the corporation and no evidence of indebtedness shall be issued in its name unless authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances. |
6.3 | Checks and Drafts. All checks, drafts or other orders for the payment of money issued in the name of the corporation shall be signed by such officer or officers, agent or agents of the corporation and in such manner as shall from time to time be determined by resolution of the Board of Directors. |
6.4 | Deposits. All funds of the corporation not otherwise employed shall be deposited from time to time to the credit of the corporation in such depositories as the Board of Directors may select. |
14
ARTICLE VII
CERTIFICATES FOR SHARES AND THEIR TRANSFER
7.1 | Certificates for Shares. The Board of Directors may authorize the issuance of some or all of the shares of the corporation's classes or series without issuing certificates to represent such shares. If shares are represented by certificates, the certificates shall be in such form as required by law and shall be determined by the Board of Directors. Certificates shall be signed (either manually or in facsimile) by the Chairman of the Board, President or a Vice President and by the Secretary or Treasurer or an Assistant Secretary or an Assistant Treasurer. The signatures of any such officers upon a certificate may be facsimiles or may be engraved or printed. In case any officer who has signed or whose facsimile or other signature has been placed upon such certificate shall have ceased to be such officer before such certificate is issued, it may be issued by the corporation with the same effect as if he were such officer at the date of its issue. All certificates for shares shall be consecutively numbered or otherwise identified and entered into the stock transfer books of the corporation. When shares are represented by certificates, the corporation shall issue and deliver to each shareholder to whom such shares have been issued or transferred, certificates representing the shares owned by him. When shares are not represented by certificates, then within a reasonable time after the issuance or transfer of such shares, the corporation shall send the shareholder to whom such shares have been issued or transferred a written statement of the information required by law to be on certificates. |
7.2 | Stock Transfer Books. The corporation shall keep a book or set of books, to be known as the stock transfer books of the corporation, containing the name of each shareholder of record, together with such shareholder's address and the number and class or series of shares held by him. Transfer of shares shall be made only on the stock transfer books of the corporation by the holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer, or by his attorney thereunto authorized by power of attorney duly executed and filed with the Secretary, and on surrender for cancellation of the certificate for such shares (if the shares are represented by certificates). All certificates surrendered for transfer (if the shares are represented by certificates) shall be cancelled before new certificates (or written statements in lieu thereof) for the transferred shares shall be issued or delivered to the shareholder. |
7.3 | Reserved. |
7.4 | Fixing Record Date. |
(a) The Board of Directors may fix a future date as the record date for one or more voting groups in order to determine the shareholders entitled to notice of or to vote at any meeting of shareholders or any adjournment thereof, or entitled to receive payment of any distribution, or in order to make a determination of shareholders for any other proper purpose. Such record date may not be more than seventy (70) days before the meeting or date on which the particular action requiring such determination of shareholders is to be taken. A determination of shareholders entitled to notice of or to vote at a shareholders' meeting is effective for any adjournment of the meeting unless the Board of Directors fixes a new record date for the adjourned meeting, which it must do if the meeting is adjourned to a date more than one hundred twenty (120) days after the date fixed for the original meeting.
(b) If no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive payment of a distribution, the close of business on the day before the first notice of the meeting is delivered to shareholders or the date on which the resolution of the Board of Directors declaring such distribution is adopted, as the case may be, shall be the record date for such determination of shareholders.
7.5 | Lost or Destroyed Certificate. The Board of Directors may direct a new certificate to be issued in place of any certificate theretofore issued by the corporation claimed to have been lost, destroyed or wrongfully taken, upon receipt of an affidavit of such fact from the person claiming the certificate of stock to have been lost or destroyed. When authorizing such issue of a new certificate, the Board of Directors shall require that the owner of such lost or destroyed certificate, or his legal representative, give the corporation a bond in such sum as the Board may direct as indemnity against any claim that may be made against the corporation with respect to the certificate claimed to have been lost or destroyed, except where the Board of Directors by resolution finds that in the judgment of the directors the circumstances justify omission of a bond. |
15
7.6 | Holder of Record. Except as otherwise required by law, the corporation may treat as absolute owner of shares the person in whose name the shares stand of record on its books just as if that person had full competency, capacity and authority to exercise all rights of ownership irrespective of any knowledge or notice to the contrary or any description indicating a representative, pledge or other fiduciary relation or any reference to any other instrument or to the rights of any other person appearing upon its record or upon the share certificate except that any person furnishing to the corporation proof of his appointment as a fiduciary shall be treated as if he were a holder of record of its shares. |
7.7 | Shares Held By Nominees. |
(a) The corporation shall recognize the beneficial owner of shares registered in the name of a nominee as the owner and shareholder of such shares for certain purposes if the nominee in whose name such shares are registered files with the Secretary of the corporation a written certificate in a form prescribed by the corporation, signed by the nominee and indicating the following: (1) the name, address and taxpayer identification number of the nominee; (2) the name, address and taxpayer identification number of the beneficial owner; (3) the number and class or series of shares registered in the name of the nominee as to which the beneficial owner shall be recognized as the shareholder; and (4) the purposes for which the beneficial owner shall be recognized as the shareholder.
(b) The purposes for which the corporation shall recognize a beneficial owner as the shareholder may include the following: (1) receiving notice of, voting at and otherwise participating in shareholders' meetings; (2) executing consents with respect to the shares; (3) exercising dissenters' rights under Article 13 of the North Carolina Business Corporation Act; (4) receiving distributions and share dividends with respect to the shares; (5) exercising inspection rights; (6) receiving reports, financial statements, proxy statements and other communications from the corporation; (7) making any demand upon the corporation required or permitted by law; and (8) exercising any other rights or receiving any other benefits of a shareholder with respect to the shares.
(c) The certificate shall be effective ten (10) business days after its receipt by the corporation and until it is changed by the nominee, unless the certificate specifies a later effective time or an earlier termination date.
(d) If the certificate affects less than all of the shares registered in the name of the nominee, the corporation may require the shares affected by the certificate to be registered separately on the books of the corporation and be represented by a share certificate that bears a conspicuous legend stating that there is a nominee certificate in effect with respect to the shares represented by that share certificate.
7.8 | Acquisition by Corporation of its Own Shares. The corporation may acquire its own shares and shares so acquired shall constitute authorized but unissued shares. Unless otherwise prohibited by the Articles of Incorporation, the corporation may reissue such shares. If reissue is prohibited, the Articles of Incorporation shall be amended to reduce the number of authorized shares by the number of shares so acquired. Such required amendment may be adopted by the Board of Directors without shareholder action. |
16
ARTICLE VIII
GENERAL PROVISIONS
8.1 | Distributions. The Board of Directors may from time to time authorize, and the corporation may make distributions to its shareholders pursuant to law and subject to the provisions of its Articles of Incorporation. |
8.2 | Seal. The corporate seal of the corporation shall consist of two concentric circles between which is the name of the corporation and in the center of which is inscribed CORPORATE SEAL. |
8.3 | Fiscal Year. The fiscal year of the corporation shall be fixed by the Board of Directors. |
8.4 | Amendments. |
(a) Except as otherwise provided herein and by law, these Bylaws may be amended or repealed and new bylaws may be adopted by the affirmative vote of a majority of the directors then holding office at any regular or special meeting of the Board of Directors.
(b) No bylaw adopted or amended or repealed by the shareholders shall be readopted, amended or repealed by the Board of Directors, unless the Articles of Incorporation or a bylaw adopted by the shareholders authorizes the Board of Directors to adopt, amend or repeal that particular bylaw or the Bylaws generally.
8.5 | Indemnification. |
(a) Any person who at any time serves or has served as a director or officer of the corporation or in such capacity at the request of the corporation for any other corporation, partnership, joint venture, trust or other enterprise, shall have a right to be indemnified by the corporation to the fullest extent permitted by law against (i) reasonable expenses, including attorneys' fees, actually and necessarily incurred by him in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (and any appeal therein), and whether or not brought by or on behalf of the corporation, seeking to hold him liable by reason of the fact that he is or was acting in such capacity, and (ii) payments made by him in satisfaction of any judgment, money decree, fine, penalty or settlement for which he may have become liable in any such action, suit or proceeding.
(b) The Board of Directors of the corporation shall take all such action as may be necessary and appropriate to authorize the corporation to pay the indemnification required by this bylaw, including without limitation, to the extent needed, making a good faith evaluation of the manner in which the claimant for indemnity acted and of the reasonable amount of indemnity due him and giving notice to, and obtaining approval by, the shareholders of the corporation.
(c) Any person who at any time after the adoption of this bylaw serves or has served in any of the aforesaid capacities for or on behalf of the corporation shall be deemed to be doing or to have done so in reliance upon, and as consideration for, the right of indemnification provided herein. Such right shall inure to the benefit of the legal representatives of any such person and shall not be exclusive of any other rights to which such person may be entitled apart from the provision of this bylaw.
17
8.6 | Advance Payment of Expenses. The corporation shall (upon receipt of an undertaking by or on behalf of the director or officer involved to repay the expenses described herein unless it shall ultimately be determined that he is entitled to be indemnified by the corporation against such expenses) pay expenses (including attorneys' fees) incurred by such director or officer in defending any threatened, pending or completed action, suit or proceeding and any appeal therein whether civil, criminal, administrative, investigative or arbitrative and whether formal or informal or appearing as a witness at a time when he has not been named as a defendant or a respondent with respect thereto in advance of the final disposition of such proceeding. |
8.7 | Directors and Officers Liability Insurance. The Board of Directors may cause the corporation to purchase and maintain “Directors and Officers Liability Insurance” for the benefit of any person who is or was serving as a director, officer, employee or agent of this corporation or for the benefit of any person who is or was serving at the request of this corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust or other enterprise. This insurance may cover any liability incurred by such person in any capacity arising out of this status as such even if the corporation would not otherwise have the power to indemnify him against that liability. |
8.8 | Effective Date of Notice. Except as provided in Section 2.5 of Article II, written notice shall be effective at the earliest of the following: (1) when received; (2) five days after its deposit in the United States mail, as evidenced by the postmark, if mailed with postage thereon prepaid and correctly addressed; or (3) on the date shown on the return receipt, if sent by registered or certified mail, return receipt requested and the receipt is signed by or on behalf of the addressee. |
8.9 | Corporate Records. Any records maintained by the corporation in the regular course of its business, including its stock ledger, books of account and minute books, may be kept on or be in the form of punch cards, magnetic tape, photographs, microphotographs or any other information storage device; provided that the records so kept can be converted into clearly legible written form within a reasonable time. The corporation shall so convert any records so kept upon the request of any person entitled to inspect the same. The corporation shall maintain at its principal office the following records: (1) Articles of Incorporation or Restated Articles of Incorporation and all amendments thereto; (2) Bylaws or restated Bylaws and all amendments thereto; (3) resolutions by the Board of Directors creating classes or series of shares and affixing rights, preferences or limitations to shares; (4) minutes of all shareholder meetings or action taken without a meeting for the past three years; (5) all written communications to shareholders for the past three years, including financial statements; and (6) a list of the names and business addresses of its current directors and officers; and (7) the corporation's most recent annual report filed with the North Carolina Secretary of State. |
8.10 | Amendments to Articles of Incorporation. To the extent permitted by law, the Board of Directors may amend the Articles of Incorporation without shareholder approval to: (1) delete the initial directors' names and addresses; (2) change the initial registered agent or office in any state in which it is qualified to do business, provided such change is on file with the applicable Secretary of State; (3) change each issued and unissued share of an outstanding class into a greater number of whole shares, provided that class is the corporation's only outstanding share class; (4) change the corporate name by substituting "corporation", "incorporated", "company", "limited" or the abbreviations therefor for a similar word or abbreviation or by adding, deleting or changing a geographic designation in the name; or (5) make any other change expressly permitted by the North Carolina Business Corporation Act to be made without shareholder action. All other amendments to the Articles of Incorporation must be approved by the appropriate voting group or groups as required by law. |
18
8.11 | Exclusive Forum for Certain Disputes. Unless the corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum, to the fullest extent permitted by law, for (i) any derivative action or proceeding brought on behalf of the corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or other employee of the corporation to the corporation or the corporation’s shareholders, (iii) any action asserting a claim against the corporation or any director or officer or other employee of the Corporation arising pursuant to any provision of the North Carolina Business Corporation Act or the corporation’s Articles of Incorporation or Bylaws (as either may be amended from time to time), or (iv) any action asserting a claim against the corporation or any director or officer or other employee of the corporation governed by the internal affairs doctrine must be a state court located within the City of Raleigh in Wake County, North Carolina or the United States District Court for the Eastern District of North Carolina. Actions filed in any North Carolina state court shall be subject to designation or assignment to the North Carolina Business Court. Notwithstanding the foregoing, this provision is not intended to apply to claims arising under the federal securities laws and the rules and regulations thereunder, including the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, to the extent applicable. |
19 |
CERTIFICATE OF ADOPTION OF BYLAWS
IN WITNESS WHEREOF, the undersigned certifies that the foregoing twenty-one (21) pages were adopted as the Bylaws of the corporation by action of the Board of Directors effective as of July 10, 2020.
/s/ Joshua Harley | |
Joshua Harley, President |
20
Exhibit 4.1
NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
FATHOM HOLDINGS INC.
WARRANT
Warrant No. | Original Issue Date: [ ], 2020 |
Fathom Holdings Inc., a North Carolina corporation (the "Company"), hereby certifies that, as partial compensation for its services as an underwriter to the Company, Roth Capital Partners, LLC or its registered assigns (the "Holder"), is entitled to purchase from the Company up to a total of [ ] shares of the Company's common stock, no par value (the "Common Stock"), at any time and from time to time from and after 180 days following the effective date of the Registration Statement on Form S-1 (File No. 333-235972), and through and including [ ], 2025, the fifth anniversary of such effective date (the "Expiration Date"), in accordance with FINRA Rule 5110, and subject to the following terms and conditions:
1. Definitions. As used in this Warrant, the following terms shall have the respective definitions set forth in this Section 1.
"Affiliate" means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 144.
"Business Day" means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.
"Common Stock" means the common stock of the Company, no par value, and any securities into which such common stock may hereafter be reclassified or for which it may be exchanged as a class.
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
"Exercise Price" means $[ ], subject to adjustment in accordance with Section 9.
"Fundamental Transaction" means any of the following: (1) the Company effects any merger or consolidation of the Company with or into another Person, (2) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (3) any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property, or (4) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property.
"New York Courts" means the state and federal courts sitting in the State of New York.
"Original Issue Date" means the Original Issue Date first set forth on the first page of this Warrant.
"Person" means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
"Prospectus" means the prospectus, dated [ ], 2020, filed with the Securities and Exchange Commission pursuant to Rule 424 promulgated under the Securities Act.
"Rule 144" means Rule 144 promulgated by the Securities and Exchange Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Securities and Exchange Commission having substantially the same effect as such Rule.
"Securities Act" means the Securities Act of 1933, as amended.
"Subsidiary" means any "significant subsidiary" as defined in Rule 1-02(w) of Regulation S-X promulgated by the Securities and Exchange Commission under the Exchange Act.
"Trading Day" means (i) a day on which the Common Stock is traded on a Trading Market, or (ii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i) or (ii) hereof, then Trading Day shall mean a Business Day.
"Trading Market" means whichever of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or OTC Markets Group electronic quotation system on which the Common Stock is listed or quoted for trading on the date in question.
"Underlying Shares" means the shares of Common Stock issuable upon exercise of this Warrant.
2. Registration of Warrant. The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the "Warrant Register"), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
3. Registration of Transfers. The Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, with the Form of Assignment attached hereto duly completed and signed, to the Company at its address specified herein. Upon any such registration or transfer, a new Warrant to purchase Common Stock, in substantially the form of this Warrant (any such new Warrant, a "New Warrant"), evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations of a holder of a Warrant.
4. Exercise and Duration of Warrants. This Warrant shall be exercisable by the registered Holder at any time and from time to time from and after 180 days following the effective date of the Registration Statement on Form S-1 (File No. 333-235972) (the "Effective Date"), through and including the Expiration Date, in accordance with FINRA Rule 5110. At 6:30 p.m., New York City time on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value. The Company may not call or redeem any portion of this Warrant without the prior written consent of the affected Holder. Neither this Warrant nor any shares of Common Stock issuable upon exercise of this Warrant, shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of this Warrant, or any security issuable upon exercise of this Warrant, by any person for a period of 180 days immediately following the effective date of the Registration Statement on Form S-1 (File No. 333-235972), except as provided in FINRA Rule 5110(g)(2).
5. Delivery of Common Stock.
(a) To effect exercises hereunder, the Holder shall not be required to physically surrender this Warrant unless all of the Warrant Shares represented by this Warrant are being exercised. Upon delivery of the Exercise Notice (in the form attached hereto) to the Company (with the attached Warrant Shares Exercise Log) at its address for notice set forth herein and upon payment of the Exercise Price multiplied by the number of Warrant Shares that the Holder intends to purchase hereunder, the Company shall promptly (but in no event later than two Trading Days after the Date of Exercise (as defined herein)) issue and deliver to the Holder, a certificate for the Warrant Shares issuable upon such exercise. The Company shall, upon request of the Holder and subsequent to the date on which a registration statement covering the resale of the Warrant Shares has been declared effective by the Securities and Exchange Commission, use its reasonable best efforts to deliver Warrant Shares hereunder electronically through the Depository Trust Corporation or another established clearing corporation performing similar functions, if available, provided, that, the Company may, but will not be required to change its transfer agent if its current transfer agent cannot deliver Warrant Shares electronically through the Depository Trust Corporation. A "Date of Exercise" means the date on which the Holder shall have delivered to the Company: (i) the Exercise Notice (with the Warrant Shares Exercise Log attached to it), appropriately completed and duly signed and (ii) if applicable, payment of the Exercise Price for the number of Warrant Shares so indicated by the Holder to be purchased.
(b) If by the second Trading Day after a Date of Exercise the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 5(a), then the Holder will have the right to rescind such exercise.
(c) If by the second Trading Day after a Date of Exercise the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 5(a), and if after such second Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a "Buy-In"), then the Company shall (1) reimburse the Holder the amount by which (x) the Holder's total purchase price (including brokerage commissions, if any) for the shares of Common Stock or Warrants so purchased exceeds (y) the amount obtained by multiplying (A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue by (B) the closing bid price of the shares of Common Stock, on the Date of Exercise and (2) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In.
(d) The Company's obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Units. Nothing herein shall limit a Holder's right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company's failure to timely deliver certificates representing Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.
6. Charges, Taxes and Expenses. Issuance and delivery of Warrant Shares upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates for Warrant Shares or Warrants in a name other than that of the Holder. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.
7. Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity (which shall not include a surety bond), if requested. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company's obligation to issue the New Warrant.
8. Reservation of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved shares of Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein provided, the number of shares of Common Stock which are then issuable and deliverable upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of Persons other than the Holder (taking into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and nonassessable.
9. Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 9.
(a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.
(b) Fundamental Transactions. If, at any time while this Warrant is outstanding there is a Fundamental Transaction, then the Holder shall have the right thereafter to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (the "Alternate Consideration"). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. At the Holder's option and request, any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant substantially in the form of this Warrant and consistent with the foregoing provisions and evidencing the Holder's right to purchase the Alternate Consideration for the aggregate Exercise Price upon exercise thereof. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this paragraph (b) and insuring that the Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction.
(c) Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 9, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.
(d) Calculations. All calculations under this Section 9 shall be made to the nearest cent or the nearest 1/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.
(e) Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company's Transfer Agent.
(f) Notice of Corporate Events. If the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any Subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice describing the material terms and conditions of such transaction (but only to the extent such disclosure would not result in the dissemination of material, non-public information to the Holder) at least 10 calendar days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction, and the Company will take all steps reasonably necessary in order to insure that the Holder is given the practical opportunity to exercise this Warrant prior to such time so as to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice.
10. Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners:
(a) Cash Exercise. The Holder may deliver immediately available funds; or
(b) Cashless Exercise. The Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Units determined as follows:
X = Y [(A-B)/A]
where:
X = the number of Warrant Shares to be issued to the Holder.
Y = the number of Warrant Shares with respect to which this Warrant is being exercised.
A = the average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date.
B = the Exercise Price.
For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.
11. Limitations on Exercise. Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise (or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder's for purposes of Section 13(d) of the Exchange Act, does not exceed 9.99% of the total number of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise). For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant. This restriction may not be waived. Notwithstanding anything to the contrary contained in this Warrant, (a) no term of this Section may be waived by any party, nor amended such that the threshold percentage of ownership would be directly or indirectly increased, (b) this restriction runs with the Warrant and may not be modified or waived by any subsequent holder hereof and (c) any attempted waiver, modification or amendment of this Section will be void ab initio.
12. No Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares which would, otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied by the closing price of one share of Common Stock as reported by the applicable Trading Market on the date of exercise, or round up to the nearest whole share of Common Stock.
13. Notices. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section prior to 6:30 p.m. (New York City time) on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be: (i) if to the Company, to Fathom Holdings Inc., Attn: Chief Executive Officer, Facsimile No.: [ ] (or such other address as the Company shall indicate in writing in accordance with this Section), or (ii) if to the Holder, to the address or facsimile number appearing on the Warrant Register or such other address or facsimile number as the Holder may provide to the Company in accordance with this Section.
14. Warrant Agent. The Company shall serve as warrant agent under this Warrant. Upon 10 days' notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder's last address as shown on the Warrant Register.
15. Miscellaneous.
(a) No Rights as a Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 5 except as expressly set forth in Section 9. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to Section 10(b) or to receive cash payments pursuant to Section 5(c) and 9(b), in no event shall the Company be required to net cash settle an exercise of this Warrant.
(b) This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder and their successors and assigns. The foregoing sentence shall be subject to the restrictions on waivers and amendments set forth in Section 11 of this Warrant.
(c) All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of this Warrant and the transactions herein contemplated ("Proceedings") (whether brought against a party hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Warrant or the transactions contemplated hereby. If either party shall commence a Proceeding to enforce any provisions of this Warrant, then the prevailing party in such Proceeding shall be reimbursed by the other party for its attorney's fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.
(d) The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.
(e) In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.
(f) Prior to exercise of this Warrant, the Holder hereof shall not, by reason of being a Holder, be entitled to any rights of a stockholder with respect to the Common Stock.
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.
FATHOM HOLDINGS INC. | ||
By: | ||
Name: | ||
Title: |
EXERCISE NOTICE
FATHOM HOLDINGS INC.
WARRANT DATED [ ], 2020
The undersigned Holder hereby irrevocably elects to purchase shares of Common Stock pursuant to the above referenced Warrant. Capitalized terms used herein and not otherwise defined have the respective meanings set forth in the Warrant.
(1) | The undersigned Holder hereby exercises its right to purchase |
__________ shares of Common Stock pursuant to the Warrant.
(2) | The holder shall pay the sum of $______________to the Company in accordance with the terms of the Warrant. |
(3) | Pursuant to this Exercise Notice, the Company shall deliver to the holder Common Stock in accordance with the terms of the Warrant. |
(4) | By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Common Stock (determined in accordance with Section 13(d) of the Securities Exchange Act of 1934) permitted to be owned under Section 11 of the Warrant to which this notice relates. |
Dated: | Name of Holder: | |||
(Print) |
By: | ||
Name: | ||
Title: |
(Signature must conform in all respects to name of holder as specified on the face of the Warrant) |
Warrant Shares Exercise Log
Date | Number of Warrant Shares Available to be Exercised | Number of Warrant Shares Exercised | Number of Warrant Shares Remaining to be Exercised |
FATHOM HOLDINGS INC.
WARRANT DATED [ ], 2020
WARRANT NO.
FORM OF ASSIGNMENT
[To be completed and signed only upon transfer of Warrant]
FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto the right represented by the above-captioned Warrant to purchase______shares of Common Stock to which such Warrant relates and appoints attorney to transfer said right on the books of the Company with full power of substitution in the premises.
Dated: | |||
(Signature must conform in all respects to name of holder as specified on the face of the Warrant) | |||
Address of Transferee | |||
In the presence of: | ||
Exhibit 5.1
![]() |
Wyrick Robbins Yates & Ponton LLP ATTORNEYS AT LAW 4101 Lake Boone Trail, Suite 300, Raleigh, NC 27607 PO Drawer 17803, Raleigh, NC 27619 P: 919.781.4000 F: 919.781.4865 www.wyrick.com |
July 16, 2020
Fathom Holdings Inc.
211 New Edition Court, Suite 211
Cary, North Carolina, 27511
Re: Registration Statement on Form S-1
Ladies and Gentlemen:
We have acted as counsel to Fathom Holdings Inc., a North Carolina corporation (the “Company”), in connection with the registration statement on Form S-1 (Registration No. 333-235972), as amended (the “Registration Statement”), and the prospectus included therein (the “Prospectus”), as publicly filed by the Company with the United States Securities and Exchange Commission (the “Commission”) on January 17, 2020, as subsequently amended on or about the date hereof, pursuant to the Securities Act of 1933, as amended (the “Act”), in connection with the registration of the offer and sale of an aggregate of up to 3,067,500 shares of the Company’s common stock, no par value per share (the “Securities”), including up to 375,000 shares purchasable by the underwriter upon exercise of an option granted to the underwriter by the Company.
This opinion is being furnished in accordance with the requirements of Item 16 of Form S-1 and Item 601(b)(5)(i) of Regulation S-K.
In connection with the foregoing, we have relied upon, among other things, our examination of such documents, records of the Company and certificates of its officers and public officials as we deemed necessary for purposes of the opinions expressed below. In our examination of documents for purposes of this opinion, we have assumed, and express no opinion as to, the authenticity and completeness of all documents submitted to us as originals, the conformity to originals and completeness of all documents submitted to us as copies, the legal capacity of all persons or entities executing the same, the lack of any undisclosed termination, modification, waiver or amendment to any document reviewed by us, and the due authorization, execution and delivery of all documents by shareholders where due authorization, execution and delivery are prerequisites to the effectiveness thereof.
Some of the Securities will be uncertificated as of the closing of the offering described in the Registration Statement.
This opinion is limited to the laws of the State of North Carolina and no opinion is expressed as to the laws of any other jurisdiction. This opinion does not extend to compliance with federal or state securities laws relating to the offer or sale of the Securities.
Fathom Holdings Inc.
July 16, 2020
Page 2 of 2
In connection with our opinions expressed below, we have assumed that, at or prior to the time of the issuance and the delivery of any Securities, the Registration Statement will have been declared effective under the Act, and the Securities will have been registered under the Act pursuant to the Registration Statement and that such registration will not have been modified or rescinded, that no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto shall have been issued in connection with the Registration Statement, and that there will not have occurred any change in law affecting the validity of the issuance of the Securities.
Based upon the foregoing, it is our opinion that up to 3,067,500 shares of the Company’s Securities to be issued and sold by the Company pursuant to the Registration Statement, when issued, sold and delivered in the manner and for the consideration stated in the Registration Statement and the Prospectus, and in accordance with the resolutions adopted by the Company’s Board of Directors (the “Board”) and to be adopted by the Pricing Committee of the Board, will be validly issued, fully paid and nonassessable.
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference of this firm under the caption “Legal Matters” in the Prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that this firm is within the category of persons whose consent is required under Section 7 of the Act or the rules and regulations promulgated thereunder by the Commission.
This opinion is intended for use in connection with issuance and sale of the Securities subject to the Registration Statement and is not to be relied upon for any other purpose. This opinion is rendered as of the date first written above and based solely on our understanding of facts in existence as of such date after the aforementioned examination. We assume no obligation to advise you of any fact, circumstance, event or change in the law or the facts that may hereafter be brought to our attention whether or not such occurrence would affect or modify any of the opinions expressed herein.
Very truly yours, | |
/s/ Wyrick Robbins Yates & Ponton LLP |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated June 15, 2020 (except for the paragraphs discussing the reverse stock split in Note 13, as to which the date is July 13, 2020), relating to the consolidated financial statements of Fathom Holdings Inc. (formerly known as Fathom Holdings, LLC) which is contained in that Prospectus.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP | |
Raleigh, North Carolina | |
July 16, 2020 |
:IQE()6 %.=(O5?R6T4FFZ=
M^$U>J5%8B+O01N[AJ_GR)C[4L#/F4!E FFD=FU9J#2%_OT:.S6UB)11IO2OC
MPDG3KXMB]:G550(7E 90+ V):K^8-:003/R4%V1*2HQWD>Y?U+^T_N>PJ@:F
M( &=NDHF.JK7S'X9Y8%190&4#7>RG^W=AYJG&4@E8 1O:3]0=
M0 Q-]0JP?N8V:^1__ ,FJ^-(/2L.SW25@J_E=GHY*294P=DJ:E6N3
MK/8Z1S'>V0"@]LR?\E7C_+?TL140G* R@;/H?X*G[VSBH17, *!Z2:8WR
MS 28/07U1B.Y:],6"U5#JBW4,=-,]BQND8BXJU5153=7KM0
M#TP .K<[5;KI3I37"!M3 CD>D;][,F*(OX0/*^@.CO),'H+ZHQ#Z Z
M.\DP>@OJC$>E:K):;3&^.W4S*9DJHZ1K,=U43#'= [H 'Q-##-&L(PDJL4@ 9(VR?W+OG?8_>6&F
MU/B2_4=A?9Y?%/OE##X-L .2FIJFJG93TT3YZB54;%#&U7O
Z HW;/;K3](8[O;*J"HCN#/WEL$C'Y9
MHT1JJJ-5<,[<.VBEA%>Y"AD O[8?J3Y?IR2T3/QJ;6["/%=U8)%56?HNQ;P)
M@25600 !16W]N.I+=S/X5Y8%79"H9 -0[-4PT)9>;IZ:F*I* '@:_
M^I-[YG-Q% RQD,D,@$CT+HN35EWFMT=4VD=%3NJ.4
M=HEHTU"Z)')575R?JJ-J^M5=YTJIZ
MU/PJ!0-ZO-QO5QEN%PE66HE7=7>:UJ;S6IU&IU$,D='* R@6OL9T6Z2?Z25L
M?ZJ/%EN8[V3]UKY<.LW>;PX]8DBX2* ,G5C?WN?OCN,IDCAR@2+9VW_ 'M9
M^<)Z2D&E2* &?MK.EOF?4KZJ!F6AN>,\6&\V3']:S])FIBJ0 !XFM_JA>.:2\50,V93)#*!86Q),-5U?,)/?HB20NPB
M@ ()MG3'2#.=Q<5Y8)49E*AE N+8:F%JN??V<0DD+,(H 0S7FSFBU
M&Q:RE5M-=V)@DOL)43>;)A^!Q11]UL]QM58^CN$#J>H9OM
O
])U2@ 8M$
MUU+V$ &8$M*LLTE
M \T5II%)9Q)80OU ?S*E3EY ;%FSX_PF\?Y
M@$-UBD2PXBC-8CUT^VXV^;O4EPFU(D(C;F]B4D,#ZV29E]*M6E0I0J96TXL<
MA8K<1(N!J6T9L,UG%>Z-;IC7$:\/$>;GPS"KQ8C#XHP_U:=)A19>*;",L-(K
M<.9$S4BMPY1'":6T:#@C5>Z+ 289Q&NZ3Z1?'\7/.J,,SKC\;8CLEI,B4LDO
M-S7]MRV\+X._:%F#X>P=^T&Z*W$T%>.DMHPXN>C1'JA+R$1M\_HT^),-?+?I
MF'[Q?Q\9NK$&OVF;?# KY;^A4L>+,>_,_[5D/"-<[%>$#[_H V;E:9
M%XX/#<[B'+6/]&.>9+-LDL,=@3M2VR&6Q:)4"3+*4J)$+*D#GEN?RU 6TR^L[9+GK3LA=@H
M Y^F%!;/4U7KP>S#]+<;9IOEJN2F&KIBAF-B"Y[4J.7
*ZL$G,OQ3WY&
M8FB?I!%1/4$@UY:>1.S$74E4OZR(B?3)7K^8S86?]C0,OD#ZIUP-32X\TEE;H)DS+K?[9D)EOJ2\A<019VFB5?]$>$Q5KK>3R-
M6C2@5D)DZ73"ES:CEZ84UN&2V@R(KM\(.IEN7